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In recent years, bioactive lipids (e.g., carotenoids, phytosterols, and tocopherols)
have attracted a lot of interest to develop health and wellness promoting foods and
beverages. However, bioactive lipids are water-insoluble and degrade easily during
processing and storage, making their addition into foods and beverages challenging.
The main objective of this thesis was to develop a novel green process to form
bioactive lipid-carrier hollow solid lipid micro- and nanoparticles using supercritical
carbon dioxide (SC-CO2). Specific objectives were to develop hollow solid lipid microand nanoparticles using SC-CO2 technology, and to load the hollow solid lipid micro- and
nanoparticles with essential oil to develop food grade free-flowing powder antibacterial.
Hollow solid lipid micro- and nanoparticles were formed from fully hydrogenated
soybean oil (FHSO) using a novel process based on atomization of CO2-expaneded lipid.
Hollow spheres (d50%= 278 nm) were obtained using 50 µm nozzle diameter and 200 bar
expansion pressure. Shell thickness of the particles decreased with increasing pressure
and nozzle diameter. Polymorphism of the particles changed from β to α by decreasing
the nozzle diameter. Melting point of FHSO decreased from 69 °C to 57 °C above 120
bar in CO2, and onset melting temperature of the particles was 50 °C due to nanosize.

Peppermint essential oil was successfully loaded into the hollow particles using the same
process to develop food grade antibacterials. The highest loading efficiency of 47.5% was
achieved at 50% initial essential oil concentration at 50 µm nozzle diameter and 200 bar
expansion pressure. The release of the loaded essential oil depended on initial essential
oil concentration, which was affected by the physical strength of the solid lipid shell.
Essential oil-loaded particles obtained at 50% initial essential oil concentration caused 3
log decrease in growth of Pseudomonas fluorescens compared to 2 log decrease with free
essential oil.
Hollow solid lipid micro- and nanoparticles are promising bioactive-carriers with
high loading capacity. Solid lipid shell protects the loaded bioactive from environmental
conditions, and provides slow release. The free-flowing powder makes handling and
storage convenient, and the simple and clean process makes the scaling up more feasible.
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This Thesis is organized as follows: introduction and thesis objectives (Chapter 1), a
literature review (Chapter 2) followed by manuscripts describing two research projects
(Chapter 3 and 4), and summary, conclusions, and recommendations (Chapter 5). All
chapters have been formatted using guidelines for Food Research International.
References can be found at the end of each chapter.
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CHAPTER 1. INTRODUCTION AND THESIS OBJECTIVES

1.1. Introduction
The growing demand for “natural” products along with the increase in diet-related
illnesses such as obesity, diabetes, cardiovascular disease, inflammation, and cancer have
led the food industry prioritize the development of health and wellness promoting foods
using bioactive compounds. Health and wellness promoting foods refer to those that
extend far beyond basic nutrition for the intended population, but could provide its
unique characteristics and thus impart desirable physiological effects and associated
health benefits. However, many of these bioactive compounds are lipophilic, resulting in
poor water solubility that requires extra processes such as emulsification to make their
addition into water possible, and have poor absorption through gastrointestinal (GI) tract
and limited bioavailability (Ting, Jiang, Ho, & Huang, 2014). Moreover, many of these
lipophilic bioactives are chemically sensitive; meaning they degrade easily in the
presence of oxygen, light, and heat during processing and storage. Therefore, effectively
including lipophilic bioactives into foods and beverages has been a major challenge for
the food industry.
The food industry has been searching for solutions to enrich foods with lipophilic
bioactive compounds while ensuring stability, bioavailability, and controlled release at
the appropriate target, as well as confirming accepted fractional influence on the
organoleptic and qualitative properties (Đorđević et al., 2015). The most common
solution to incorporate lipophilic bioactives into foods has been encapsulation where the
bioactive is entrapped in a matrix, which provides protection from environmental
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conditions, and allows modification of the physical properties to improve solubility
compatibilities between bioactive compounds and the established food matrix (Dube,
Ken, Nicolazzo, & Ian, 2010; Helgason, Awad, Kristbergsson, McClements, & Weiss,
2009; Hentschel, Gramdorf, Müller, & Kurz, 2008). From a technological point of view,
there are some desirable characteristics required to achieve an efficient delivery system
for bioactive compounds: (1) it must consist of only food grade materials; (2) it must be
economic and easy to scale up; (3) it must protect the sensitive bioactives from
degradation; (4) it should possess high loading capacity and longer retention before
targeted release; and (5) it should maximize the uptake of encapsulated bioactives and
enhance the bioavailability of the compound (McClements, Decker, Park, & Weiss, 2009;
Đorđević et al., 2015).
Lipids are promising delivery vehicles for lipophilic bioactives mainly due to
their biocompatibility (Dolatabadi, Valizadeh, & Hamishehkar, 2015; Severino et al.,
2012). Additionally, lipid-based carriers should be able to target delivery inside the body
through either active (e.g., by incorporating antibodies) or passive (e.g., based on particle
size) mechanism (Mozafari & Mortazavi, 2005; Mozafari, 2006). Moreover, several
studies have reported that encapsulation of bioactive compounds through lipid-based
carrier systems may improve their therapeutic potential by facilitating intracellular
delivery and prolonging their retention time inside the cell (Suntres, 2011; Çağdaş, Sezer,
& Bucak, 2014).
Solid lipid nanoparticles have been developed as one of the latest generation of
drug carriers, and recently they have been proposed as the new generation of lipophilic
bioactive-carriers for food applications. However, they have limited bioactive loading
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capacity, and tend to expel the loaded bioactive during crystallization due to their solid
lipid core. Moreover, current solid lipid nanoparticles are currently produced using an
energy-intensive high-pressure homogenization method that generates liquid products.
This thesis reports the development of free-flowing powder hollow solid lipid micro- and
nanoparticles that will overcome the low loading capacity and bioactive expelling
problems using a novel green process based on supercritical carbon dioxide (SC-CO2)
technology. The resultant powder formula makes the handling, transportation and storage
convenient, while the nanosize particles make the addition of lipophilic bioactives into
beverages possible, and the green process does not use hazardous or toxic solvents and
limits environmental pollution.

1.2. Hypothesis
It was hypothesized that atomization of a CO2-expanded lipid mixture through a
nozzle can form hollow solid lipid micro- and nanoparticles. It was also hypothesized that
atomization of a CO2-expanded mixture of solid lipid and essential oil through a nozzle
can form essential oil-loaded hollow solid lipid micro- and nanoparticles, and further, the
solid lipid shell provides slow release of the loaded essential oil, which results in
improved antibacterial activity.

1.3. Thesis objectives
The main objective was to develop a novel green process to form bioactive lipidcarrier hollow solid lipid micro- and nanoparticles using SC-CO2. The specific objectives
were to:
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1) Develop hollow solid lipid micro- and nanoparticles using a green process based on
SC-CO2 technology; and
2) Load the hollow solid lipid micro- and nanoparticles with essential oil to develop food
grade free-flowing powder antibacterials.
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CHAPTER 2. LITERATURE REVIEW

2.1. Bioactive compounds
Bioactive compounds are extra nutritional constituents that typically occur in
small quantities in foods (Kris-Etherton et al., 2002). They are being intensively studied
to evaluate their effects on health. Clinical studies have demonstrated that intaking
bioactive compounds as part of consumers’ daily diet may exert tangible health benefits
(Stewart & Kleihues, 2003). Moreover, increases in dietary-intake-related illnesses such
as obesity, type-2 diabetes, cardiovascular disease and cancer have led the food industry
prioritize the development of health and wellness promoting foods using bioactive
compounds.
Bioactive lipids (e.g., carotenoids, omega-3 fatty acids, tocopherols, and
phytosterols) are a group of lipophilic bioactives that are water-insoluble and widely
differ in their molecular, physicochemical and physiological properties. Carotenoids have
been proposed to exhibit several potential health benefits: lutein and zeaxanthin to
decrease age-related macular degeneration and cataracts (Stringham & Hammond, 2005),
and lycopene to decrease the risk of prostate cancer (Basu & Imrhan 2007). Omega-3
fatty acids, particularly, eicosapentaenoic acid (EPA, 20:5) and docosahexaenoic acid
(DHA, 22:6) decrease the risks of cardiovascular disease, fight diseases affected by
immune response disorders, and mental disorders, as well as benefit infant development
(Fidler, Sauerwald, Pohl, Demmelmair, & Koletzko, 2000; Makrides & Gibson, 2000;
Hibbeln, Nieminen, Blasbalg, Riggs, & Lands, 2006; Jensen, 2006). Tocopherols have
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the potential to decrease the risks of coronary heart disease, cancer, and urinary tract
disease (McClements, Decker, & Weiss, 2007). Phytosterols could decrease the risk of
coronary heart disease by reducing total and low-density lipoprotein cholesterol in
humans through inhibiting the absorption of dietary cholesterol (Wong, 2001; Ostlund,
2004).
However, there are some problems associated with the efficient utilization of
these lipophilic bioactives by both consumers and food industry: 1) they may not be
possible to intake with diet properly; 2) they are tightly bound to the food matrix and
water-insoluble, resulting poor bioavailability; and 3) they are chemically unstable,
meaning they degrade easily during processing and storage. Therefore, effectively
incorporating lipophilic bioactives into foods and beverages has been a major challenge.
To enrich foods with lipophilic bioactive compounds while ensuring stability,
bioavailability, controlled release, and accepted organoleptic and qualitative properties,
the food industry came up with a common solution: to entrap lipophilic bioactives in a
matrix as delivery system (Đorđević et al., 2015). The matrix provides the protection of
the encapsulated bioactive from environmental conditions such as temperature, oxygen,
pH, and allows modification of the physical properties to improve solubility
compatibilities between bioactive compounds and the established food matrix (Dube et
al., 2010; Helgason et al., 2009; Hentschel et al., 2008). With a suitable delivery system,
the in vivo fate of the bioactive compound is no longer determined by only its properties
but by those of the delivery system (McClements et al., 2007).
Lipids have attracted much attention as delivery vehicles for lipophilic bioactives
because they are digestible, often facilitate the absorption of bioactive in the small
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intestine, could entrap material with different solubilities and can be produced using food
grade lipids on an industrial scale (Dolatabadi et al., 2015; Severino et al., 2012;
Anandharamakrishnan, 2013; Mozafari & Mortazavi, 2005).

2.2. Lipid-based delivery systems
Recent developments of lipid-based delivery systems for efficiently incorporating
various lipophilic bioactives include emulsions, liposomes, solid lipid nanoparticles
(SLN), and nanostructured lipid carriers (NLC). In this section, these lipid-based delivery
systems are described in terms of their production methods, applications and features, and
advantages and limitations.

2.2.1. Emulsions
Emulsions are colloidal delivery systems, basically consist of oil phase, water
phase and surfactant, and can be classified based on particle size into macroemulsions (~
μm), microemulsions (5-100 nm) and nanoemulsions (20-300 nm). Macroemulsions and
nanoemulsions are kinetically stable but thermodynamically unstable, tend to break down
during storage. Nanoemulsions are more resistant to oxidation than microemulsions,
which are thermodynamically stable, low viscous, easy to prepare but always require
higher concentrations of a surfactant typically with a co-surfactant, therefore,
microemulsions has not been established certain food grade systems for delivery these
lipophilic bioactives (Đorđević et al., 2015).
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2.2.1.1. Production methods
Emulsions are typically produced using mechanical (high-energy) or nonmechanical method. Mechanical (high-energy) methods include high-pressure
homogenization (HPH), microfluidization, and ultrasonication. In addition, solvent
diffusion method is one example of non-mechanical techniques to produce
nanoemulsions (Tadros, Izquierdo, Esquena, & Solans, 2004; Unger et al., 2004).
High-pressure homogenizers push the coarse dispersion of the mixture with high
pressure in the range of 35-345 bar through a narrow gap (a few microns). Due to the
acceleration of fluid over a very short distance with very high velocity (over 1000 km/h),
very high shear stress and cavitation forces disrupt the particles down to the submicron
range (Fathi, Mozafari, & Mohebbi, 2012). A recent example of the technology was
when Yuan, Gao, Mao, and Zhao (2008) formed β-carotene O/W nanoemulsions. They
found that the chemical stability of the nanoemulsions decreased with increasing
temperature but increased with pressure (up to 100 bar) and cycle numbers (up to 3).
Moreover, β-carotene showed great stability with less loss in the first four weeks of
storage at room temperature.
In microfluidization, a high-pressure (up to 1380 bar) to force the liquid
dispersions through an interaction chamber in which microchannels are placed, and very
fine particles in submicron range are produced. The emulsification mechanism is based
on shear and cavitation forces. The operating pressure and number of passes play
important roles in particle size of the obtained nanoemulsion (Constantinides, Chaubal, &
Shorr, 2008; Maa & Hsu, 1999).
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Emulsification by the ultrasonication method is attributed to bubble cavitation.
The ultrasonic waves result in sequential formation, growth and collapse of microscopic
vapor bubbles in the liquid. Consequently, the collapse of these cavities provides
sufficient energy to increase surface area of droplets (Patil & Pandit, 2007).
Comparing these three high-energy mechanical methods, the use of HPH and
ultrasonication may cause degradation or denaturation of the sensitive molecules being
encapsulated, whereas the microfluidization was found to be more effective due to the
smaller droplet diameters and less droplet diameter growth during storage (Fathi et al.,
2012).
Nanoemulsions can also be obtained using solvent diffusion method (Tadros et
al., 2004; Unger et al., 2004). Typically, the oil phase consists of oil carrier, lipophilic
surfactant and hydrophilic organic solvent, and the aqueous phase consists of hydrophilic
surfactant and water. Fine O/W emulsion can be produced by passing through a highpressure homogenizer, then the solvent is removed by evaporation (Jaiswal, Gupta, &
Kreuter, 2004; Mainardes & Evangelista, 2005). However, one limitation of this
technique is the use of large amount of organic solvent; therefore, high energy and
expensive equipment is required to remove organic solvent before completion of final
product. In general, application of the low energy methods is limited in food sectors due
to the need of organic solvent in those methods (Fathi et al., 2012).

2.2.1.2. Applications and features
Emulsions have been used to encapsulate and deliver various lipophilic
bioactives. For example, omega-3 fatty acids have been entrapped into food products

11

such as milk, yogurt, ice cream, and meat patties to protect omega-3 from oxidation
(McClements & Decker, 2000; Chee et al., 2005, 2007; Sharma, 2005; Lee, Faustman,
Djordjevic, Faraji, & Decker, 2006; Belhaj, Arab-Tehrany, & Linder, 2010). Application
of emulsions as delivery systems of functional components, including lutein (Losso,
Khachatryan, Ogawa, Godber, & Shih, 2005), lycopene (Ribeiro et al., 2003; 2006), βcarotene (Santipanichwong & Suphantharika, 2007; Yuan et al., 2008), curcumin (Wang
et al., 2008), α-tocopherol (Cheong, Tan, Man, & Misran, 2008), and phytosterol (Leong
et al., 2011) have been reported. For those bioactives which are crystalline at ambient
temperatures, they are used either at levels below their saturation concentration in the
carrier oil, or the lipid phase is melted before homogenization, thus decreasing the
problems associated with emulsion formation and/or stability (McClements et al., 2007).

2.2.1.3. Advantages and limitations
Emulsions are currently being used as delivery systems in various industries,
including pharmaceuticals, cosmetics, and foods. They can provide a number of potential
advantages to carry and deliver nutraceutical and functional food components, for
example, it is possible to incorporate active ingredients that are water-soluble, waterinsoluble, and amphiphilic at the same time within the same delivery system
(McClements et al., 2007, 2009; McClements, 2005). Additionally, the heterogeneous
structure offers an opportunity to develop novel techniques for controlling the chemical
stability of encapsulated bioactives (Coupland & McClements, 1996; McClements &
Decker, 2000).
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Nevertheless, several limitations have restricted the prevalence of emulsions as
delivery system, and therefore, more sophisticated structured systems are needed. The
major problem is that emulsions are vulnerable to degradation when exposed to
environmental conditions change, such as temperature and pH. In addition, emulsions are
not physically stable in the liquid state, causing phase separation during storage.
Moreover, rapid release of entrapped functional components due to the smaller size and
the liquid state of the carrier, low stability in gastric condition, and long-term instability
during storage are the major disadvantages (Benichou, Aserin, & Garti, 2002; Dickinson,
2003; Drusch, 2007; McClements et al., 2009; Fathi et al., 2012). Furthermore, emulsions
are liquid products. In order to obtain a dry formulation, they must be dried to make
handling, transportation, and utilization in some applications more convenient
(Soottitantawat, Yoshii, Furuta, Ohkawara, & Linko, 2003; Desai & Park, 2005;
Klinkesorn, Sophanodora, Chinachoti, McClements, & Decker, 2005; Vega & Roos,
2006).

2.2.2. Liposomes
Liposomes are microscopic vesicles composed of a membrane, usually
phospholipid bilayers, surrounding an aqueous medium. Liposomes have been widely
used for targeted drug delivery, but increasing interest for the delivery of the functional
compounds has emerged in the recent decade. The mechanism of liposome formation is
based on the unfavorable interactions between amphiphilic compounds (primarily
phospholipids) and water molecules (Goyal et al., 2005; Jesorka & Orwar, 2008). Due to
the special structure consisting of both lipid phase and water phase, liposomes can be
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utilized to encapsulate water-soluble, lipid-soluble, and amphiphilic materials.
Furthermore, liposomes are efficient in entrapping and stabilizing bioactives against
environmental conditions and providing better protection (Mozafari & Khosravi-Darani,
2007). Similar to emulsions, liposome formation is based on the interaction of
hydrophilic and lipophilic interactions between phases of lipid/lipid and lipid/water
(Goyal et al., 2005).

2.2.2.1. Production methods
Mechanical and non-mechanical methods have been developed to produce
liposomes. Mechanical techniques include HPH, microfluidization, sonication, and
extrusion. Non-mechanical techniques include reversed-phase evaporation and lipid
hydration followed by vortex or manual stirring (Lasch, Weissing, & Brandl, 2003;
Schroeder, Kost, & Barenholz, 2009). It has been shown that ultrasonic cavitation
induced mechanical shear is an ideal method as it results in having particle size
distribution in a narrower range than other methods (Maulucci et al., 2005; Moran et al.,
2006).

2.2.2.2. Applications and features
In the recent decade, liposomes have been investigated as delivery systems for
enzymes (Jahadi et al., 2012, Smith, Jaime-Fonseca, Grover, & Bakalis, 2010), proteins
(Sun-Waterhouse & Wadhwa, 2013), vitamins (Gonnet, Lethuaut, & Boury, 2010),
flavors (Nedovic, Kalusevic, Manojlović, Petrovic, & Bugarski, 2013; Yoshida, Yokota,
Foglio, Rodrigues, & Pinho, 2010), minerals (Evens et al., 2012), antioxidants (Isailović
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et al., 2013; Kerdudo, Dingas, Fernandez, & Faure, 2014; Rashidinejad, Birch, SunWaterhouse, & Everett, 2014), and antimicrobials (Boualem, Subirade, Desjardins, &
Saucier, 2013; Malheiros, Sant’Anna, Barbosa, Brandelli, & Franco, 2012). Liposomes
have been also used to entrap polyphenolic compounds (Kerdudo et al., 2014; Pravilović,
Radunović, Bošković-Vragolović, Bugarski, & Pjanović, 2014). Encapsulation of
material in liposomes could help protect against environmental changes (Augustin &
Hemar, 2009).

2.2.2.3. Advantages and limitations
Large-scale production and delivery of both water-soluble and lipid-soluble
ingredients are the predominate perks. Nevertheless, rapid release of the encapsulated
bioactive due to the smaller size and the liquid state of the carrier, low stability in gastric
condition, and long-term instability during storage are the major disadvantages associated
with liposomes (Fathi et al., 2012). Moreover, liquid state, high expenses and timeconsuming manufacturing processes limit the application of liposomes in food systems
(Đorđević et al., 2015).

2.2.3. Solid lipid nanoparticles
SLN have attracted increasing attention as delivery systems of drugs and
lipophilic food bioactives in the recent decade, but their potential for food applications
has not been fully explored yet (Awad et al., 2008; Gallarate, Trotta, Battaglia, & Chirio,
2009; Taylor, Gaysinsky, Davidson, Bruce, & Weiss, 2007; Varshosaz et al., 2010). SLN
are particles in the submicron range and composed of solid lipid, dispersed in water or
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aqueous surfactant solution. The solid lipid matrixes are typically mono-, di- or
triacylglycerol, with the lipophilic bioactives being a part of the lipid matrix (Jenning,
Thünemann, & Gohla, 2000). Different from emulsions, SLN are submicron-sized
particles in which the liquid oil is replaced by solid fat at room temperature or at body
temperature, which could provide better protection of encapsulated material and achieve
controlled release due to lower mobility in solid fat rather than in liquid oil (Pardeshi et
al., 2012).

2.2.3.1. Production methods
2.2.3.1.1. High-pressure homogenization
HPH is a basic technique which enables the large-scale production of SLN. The
lipid contents vary depending on different applications using HPH, typically are in the
range of 5-10% but could go higher (up to 40%) forming lipid nanodispersions
(Anandharamakrishnan, 2013).
In hot HPH method, firstly the solid lipid is melted at 5-10 °C above its melting
point, then bioactive is dispersed in the lipid phase along with an aqueous surfactant
under the same temperature. After premixing and forming a coarse free-emulsion, the
mixture is passed through a high-pressure homogenizer above the lipid melting point and
result in a hot O/W nanoemulsion. Cooling down to the room temperature leads to the
solidification of the obtained nanoemulsion and the formation of SLN (Fathi et al., 2012;
Anandharamakrishnan, 2013; Shin, Kim, & Park, 2015). Lyophilization could also be
applied to initiate recrystallization of the lipid (Müller, Mäder, & Gohla, 2000).
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The advantages of hot HPH technique include: 1) easy to scale up; 2) short
production time; and 3) controlled smaller particle size with narrow size distribution.
However, hot HPH has some limitations. Due to the loss of the lipophilic bioactive to the
water phase, hot HPH may not efficiently incorporate these compounds into the solid
matrix. Secondly, for those heat sensitive functional compounds such as enzyme and fish
oil, hot HPH cannot be applied to obtain ideal particles. Finally, since most surfactant
have low cloud point, which is the temperature above which an aqueous solution of a
water-soluble surfactant becomes turbid, the presence of high temperatures may reduce
the emulsifying capability and impact particle stability (Fathi et al., 2012).
Cold HPH has been proposed to address these problems. Similar to the first step
in hot HPH, the bioactive is incorporated into a melted lipid. Then, the mixture is cooled
down either in liquid nitrogen or dry ice, and grounded by a powder mill with particle
size of 50-100 µm. The grounded powder are dispersed in an aqueous cold surfactant
solution at room temperature and premix together. Finally, the lipid suspension is
homogenized at or below room temperature to produce SLN (Pardeshi et al., 2012). For
this cold HPH technique, special care must be employed since the temperature may rise
during milling and homogenization (10-20 °C per cycle) (Fathi et al., 2012; Weiss et al.,
2008). Cold HPH enables processing heat sensitive or water-soluble food compounds.
Additionally, crystallization process is controllable and desired crystal structure could be
successfully formed by rapid cooling procedure. However, a major drawback of this cold
HPH technique could be larger particle size and broader size distribution, and therefore
do not possess a uniform dissolution when masticated and digested (Weiss et al., 2008).
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An example of the technology was performed by Schubert and Müller-Goymann
(2005), who incorporated bovine serum albumin (BSA) in solid hydrogenated palm oil
nanoparticles using HPH technique. They found that the addition of lecithin up to 30%
(w/w) in the lipid posed a concentration-dependent decrease of particle size to 100 nm. In
addition, Sun et al. (2013) developed curcumin-loaded SLN using hot HPH method with
liquid lipid propylene glycol monocaprylate. They obtained curcumin-loaded SLN which
had a mean particle size of 153 nm and achieved 90% encapsulation efficiency. They also
reported that the SLN delivery could improve the dispersity and chemical stability of
curcumin, elongate their antitumor activity and cellular uptake, and further enhance the
bioavailability.

2.2.3.1.2. Microemulsion formation
Microemulsion formation is another method to produce SLN. This method is
based on the dilution of a microemulsion in water that leads to precipitation of the lipid
phase, thus forming particles (Gasco, 1997). Typically, microemulsions are produced by
stirring an optically transparent lipid mixture at 65-70 °C which is normally composed of
high melting fatty acid (stearic acid), emulsifier and water. Then, the hot microemulsion
is dispersed in cold water under stirring, with the volume ratio of the hot microemulsion
to cold water usually are in the range of 1:25 to 1:50 (Flanagan & Singh, 2006). Finally,
the excess water is removed by either by ultrafiltration or lyophilization to condense the
particle concentration (Weiss et al., 2008). Tiyaboonchai, Tungpradit, and
Plianbangchang (2007) produced curcuminoid-loaded SLN at 75 °C. Under optimum
processing conditions, lyophilized curcuminoid-loaded SLN had spherical shape with a
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mean particle size of 450 nm and encapsulation efficiency of 70%, and in vitro release
was prolonged for up to 12 h. Moreover, lyophilized curcuminoid-loaded SLN showed
good physical and chemical stability over the 6-month storage period. Low mechanical
energy input and theoretical stability are the advantages of microemulsions method;
however, extremely sensitive to changes in the processing parameters, labor intensive
work, and low nanoparticle concentrations are its limitations (Ekambaram, Sathali, &
Priyanka, 2012).

2.2.3.1.3. Ultrasonication
SLN can also be prepared by ultrasonication. For smaller particle size, a
combination of high-speed homogenization and ultrasonication is required. Nayak,
Tiyaboonchai, Patankar, Madhusudhan, and Souto (2010) produced curcuminoid-loaded
SLN by combining high-speed homogenization and ultrasonication. The particles had
spherical shape with sizes ranging between 120 and 250 nm. The encapsulation
efficiency was between 80-94% and the loading capacity was between 1-3%. The
advantages of this method include reduced shear stress and the need for only simple
equipment (Ekambaram et al., 2012). Potential metal contamination, large particle size
due to low dispersion quality, and physical instability (e.g., particle growth during
storage) are the major concerns with the technique (Ekambaram et al., 2012; Üner, 2006).
Moreover, lipid concentration tends to be low (<1%) and the surfactant concentration is
comparatively high (Wissing, Kayser, & Müller, 2004).
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2.2.3.1.4. Solvent emulsification-evaporation or -diffusion
This technique is based on SLN dispersions by precipitation in O/W emulsions.
During this procedure, addition of water to the organic solution with lipophilic material
under mechanical agitation would result in coacervation and formation of lipid
nanoparticles (Quintanar-Guerrero, Allémann, Fessi, & Doelker, 1999). Avoidance of
heat is the most important advantage of this method. However, in this technique, because
of the limited solubility of the lipid in organic solvents, it usually needs dilution of the
suspension, therefore, the particle concentration (up to 15%) is lower than the one
obtained by HPH technique. Additionally, solvent residues may pose toxicological
problems (Trotta, Debernardi, & Caputo, 2003).

2.2.3.2. Applications and features
Three models of incorporating bioactive components into SLN have been
proposed: homogeneous matrix model, bioactive-enriched shell model and bioactiveenriched core model. Production method and formulation components (lipid, lipophilic
bioactive and surfactant) play important role in determining the SLN model. A
homogeneous matrix will likely be formed when cold homogenization method is used
and very lipophilic bioactives are incorporated using hot homogenization method. In this
case, dissolution of the homogeneous matrix dictates the bioactive release. A bioactiveenriched shell model could be produced if phase separation happens during cooling of the
liquid lipid to a solid. On the other hand, a bioactive-enriched core model might be
formed if the bioactives solidify first and as a result, the shell would have less bioactives
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when it begins solidifying. Passive diffusion governs this type of SLN model to release
the loaded bioactive (Fathi et al., 2012).
To ensure the physical stability of SLN, zeta potential is commonly used to
quantify surface charge (Bunjes, 2005; Lim & Kim, 2002). Charged particles possessing
high zeta potential are less likely to suffer nanoparticle aggregation due to electric
expulsion (Mehnert & Mader, 2001). It is also important to recognize that, after oral
administration, due to the ionic strength and strong pH changes in GI tract, nanoparticles
are likely to destabilize and this can lead to aggregation and size growth. However,
Zimmermann and Müller (2001) demonstrated that by having SLN with larger than 8-9
mV zeta potential and in combination with steric stabilization, it is possible to produce
stable SLN in GI environment. Loading capacity of SLN could be greatly affected by
solubility of bioactive in melted lipid, structures of the solid lipid matrix and polymeric
state of the lipid material (Fathi et al., 2012). The additions of solubilizers such as monoand diacylglycerols could help boost bioactive solubility in lipid and therefore increase
loading capacity. Crystallization of the lipid nanoparticles is different than the bulk lipid
material. For bulk lipid, it tends to recrystallize in β’ form and rapidly transformed to β
form, whereas for lipid nanoparticles, it at least partially recrystallizes in α form
(Westesen, Siekmann, & Koch, 1993). In order to produce SLN with delayed
polymorphic form from α to β, changing fat type or using surfactant with hydrocarbon
tails that crystallize before lipid could help preventing nanoparticle aggregation and
storing at low temperatures (Awad et al., 2008; Helgason et al., 2009). To keep it
physically and chemically stable, lyophilization with cryo-protective agents has been
demonstrated as an effective technique (Mehnert & Mader, 2001). Generally, for the
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production of SLN, relatively high melting-point lipids (melting point >70 °C) is
recommended (Mehnert & Mader, 2001).
Patel and Martin-Gonzalez (2011) encapsulated ergocalciferol (vitamin D2) in
tripalmitin SLN stabilized by Tween 20 using hot HPH technique. The particle size of
ergocalciferol-loaded SLN gradually decreased from 120 nm to 65 nm with increasing
ergocalciferol content up to 20% (w/w). They also observed that the turbidity of SLN
dispersions reduced noticeably with increasing ergocalciferol loading, indicating it could
be useful for fortification of clear water-based drink. Qian, Decker, Xiao, and
McClements (2012) have encapsulated β-carotene and studied the effect of lipid
compositions on formulations. They found out that liquid lipid nanoparticles showed
better stability to β-carotene than SLN, and suggested that cocoa butter and hydrogenated
palm oil mixtures were too well packed and led to the expulsion of β-carotene.

2.2.3.3. Advantages and limitations
SLN are delivery systems for drugs and bioactives alternative to emulsions and
liposomes due to their advantages (Cavalli, Gasco, Chetoni, Burgalassi, & Saettone,
2002; Illing & Unruh, 2004; Müller et al., 1995): 1) most lipids and surfactants used in
preparation have “Generally Recognized As Safe” (GRAS) status (Code of Federal
Regulations, Food and Drugs, 2001); 2) stable formulations can be developed; 3) SLN
production using HPH technique is highly reproducible (Gohla & Dingler, 2001; Tabatt,
Sameti, Olbrich, Müller, & Lehr, 2004); 4) possibility of large-scale production (Gohla &
Dingler, 2001; Tabatt et al., 2004); 5) effective protection of bioactives against chemical
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degradation; and 6) more controlled release of encapsulated compounds due to the solid
matrix.
Nevertheless, there are several disadvantages associated with SLN, including: 1)
poor loading capacity due to solid lipid core and limited solubility of the active ingredient
in the lipid phase; 2) expulsion of the loaded active ingredient after liquid-to-solid phase
transition during storage; and 3) burst release which is due to the presence of active
ingredient in the outer shell (Tabatt et al., 2004; Fathi et al., 2012).

2.2.4. Nanostructured lipid carriers
NLC are colloidal carriers featured as a solid lipid core with a mixture of both
solid and liquid lipids with mean particle size falling into nanometer range
(Anandharamakrishnan, 2013). NLC are considered as a modified version of SLN and the
second generation of lipid nanoparticles (Müller, Radtke, & Wissing, 2002). In general,
NLC possess the advantages of SLN, including low toxicity, biodegradation, protection,
slow release, and elimination of organic solvents use, but also be able to overcome the
limitations of SLN by creating a less ordered lipid matrix with many imperfections,
which could allow for a higher loading capacity and decrease the risk of expelling of
bioactives during storage (Fathi et al., 2012; Tamjidi, Shahedi, Varshosaz, & Nasirpour,
2013; Pardeshi et al., 2012). Due to the improved stability, high loading capacity and
controlled release, NLC are widely used in the pharmaceutical field (Naseri, Valizadeh,
& Zakeri-Milani, 2015).
There are several requirements needed for creating a suitable lipid blend for NLC
(Tamjidi et al., 2013). Firstly, the solubility of the active compound in lipid matrix is
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essential, as this influences loading capacity and the subsequent usefulness of the NLC
(Jaspart, Piel, Delattre, & Evrard, 2005; Kasongo, Pardeike, Müller, & Walker, 2011).
Secondly, the liquid and solid lipids should be spatially incompatible, meaning the oil
molecules should not be participated in the solid crystalline matrix of solid lipid and the
crystals of solid lipid should not be dissolved in the liquid lipid. Moreover, it is a
prerequisite that the liquid and solid lipids used to form NLC are miscible at specific
concentration; this means that macroscopic phase separation should not be occurred at a
temperature below melting point of fat (Kasongo et al., 2011; Radtke & Müller, 2001).
Thirdly, stability of the lipid phase should be confirmed, particularly as it relates to
oxidation and lipolysis stability (Tamjidi et al., 2013). Fourth, the lipid phase should be
biodegradable and able to easily produce NLC in the nanometer range, normally with a
low viscosity or interfacial tension (Walstra, 2003). Finally, accepted toxicological
profile of the lipid should be met to produce NLC (Tamjidi et al., 2013). Typically, lipids
used to prepare NLC are mono-, di- and triacylglycerols, fatty acids and waxes (Tamjidi
et al., 2013).

2.2.4.1. Production methods
Compared to emulsions and liposomes, NLC can retain the encapsulated
compound better and also prevent particles from coalescing by solid lipid matrix (Üner,
2006). As a matter of fact, the addition of a certain nanostructure could enhance the
encapsulation load of bioactives and limit the expulsion phenomenon (Chen, Han, Cai, &
Tang, 2010; Müller et al., 2002). NLC can be produced by simply mixing solid and liquid
lipids, together with surfactants, leading to a less perfect solid with imperfections or
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amorphous type (Üner, 2006; Shin et al., 2015; Anandharamakrishnan, 2013). Similar to
SLN, NLC can be manufactured through HPH (either cold or hot), microemulsion
formation, ultrasonication, high shear homogenization, or/and solvent emulsificationevaporation methods (Üner, 2006; Gasco, 1993; Trotta et al., 2003). It is also reported
that the particle size is smaller compared to SLN (Fang, Fang, Liu, & Su, 2008).

2.2.4.2. Applications and features
NLC are an advanced delivery system and appeared to possess the advantages
associated with emulsions, liposomes and SLN, but at the same time, overcome some of
the problems of SLN such as limited loading capacity and expulsion during storage
(Westesen & Siekmann, 1997; Pardeshi et al., 2012). Lacatusu, Badea, Ovidiu, Bojin, and
Meghea (2012) loaded lutein in NLC with omega-3 fatty acids as a liquid oil and
carnauba wax and glycerol stearate as solid lipid. They reported that the particle size was
below 200 nm and the loading efficiency reached up to 89%. In addition, a high blocking
effect and oxygen scavenging of 98% was also demonstrated. Curcumin-loaded NLC
were also studied for intragastric administration (Fang et al., 2012). Their results
proposed that NLC are promising delivery system for improving solubility of waterinsoluble bioactives such as curcumin. Additionally, β-carotene was successfully
entrapped in NLC by HPH technique with Tween 80 as emulsifier (Hentschel et al.,
2008). The mean diameter was 144 to 249 nm, and the particle size decreased as the
emulsifier concentration increased. During the storage period, the mean particle size was
around 0.3 µm of 9 weeks at 20 °C and 30 weeks at 4-8 °C. Furthermore, the addition of
tocopherol improved the stability of β-carotene-loaded NLC.
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2.2.4.3. Advantages and limitations
Compared to conventional carriers, NLC have some distinct advantages. Firstly,
they can increase the solubility of the bioactive materials since the solubility of lipophilic
bioactive compounds tends to be higher in liquid oils than in solid fats (Tamjidi et al.,
2013). Secondly, NLC have the ability to enhance storage stability due to reduced
mobility in the solid phase and could improve permeability and bioavailability of the
bioactive materials (Tamjidi et al., 2013; Pardeshi et al., 2012). Finally, with the addition
of liquid oil in the solid fat, NLC could increase payload capacity compared to SLN
(Jenning et al., 2000; Westesen & Siekmann, 1997).
The major disadvantage associated with NLC is the occurrence of partial
coalescence. This phenomenon would happen if lipid particles are partly crystalline, then,
a crystal from one particle can penetrate into the liquid oil portion during a contact or
collision which causes the particles to stick together, and may lead to a decrease in NLC
stability to aggregation or gelation (Tamjidi et al., 2013). Various factors that could
influence partial coalescence have been discussed elsewhere (McClements, 2005;
Walstra, 2003). Based on those discussions, the types of lipids and emulsifiers, the ratio
of solid to liquid lipid and the particle size pose significant influences on partial
coalescence. If nanoparticles have amorphous structure with no presence of any crystal,
then we would not expect any partial coalescence in NLC to occur (Tamjidi et al., 2013).
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2.3. Supercritical fluid (SCF) technology
2.3.1. Introduction
A supercritical fluid (SCF) is defined as a fluid for which both pressure and
temperature are above its critical point (Fig. 2.1), namely Pc and Tc, respectively
(Subramaniam, Rajewski, & Snavely, 1997; Nalawade, Picchioni, & Janssen, 2006).
When pressure and temperature are very close to the critical point, the fluid reveals
unique physical properties that are significantly different from its normal behavior, in
which it is neither liquid nor gas but possesses the properties of both (Montes, Gordillo,
Pereyra, & Martinez de la Ossa, 2011). SCF shows a density similar to a liquid, and
appreciable for solvent power, while the gas-like viscosity and diffusivity facilitate
increased rates of mass transfer (Pasquali, Bettini, & Giordano, 2008). SCF is dense but
highly compressible, in particular near the supercritical region. The density of SCF can
be easily tuned by small changes in pressure within the critical region, and consequently
the solvent power can be affected (Subramaniam et al., 1997; Nalawade et al., 2006;
Montes et al., 2011; Brunner, 2005). The special combination of gas-like viscosity,
diffusivity, and compressibility and liquid-like density of a SCF makes it excellent for
various applications such as solvents, antisolvent, or solute in polymer and lipid
processing: e.g. polymer modification, polymer blending, polymer synthesis, lipid
extraction and particle formation (Nalawade et al., 2006; Cooper, 2000; Tomasko et al.,
2003; Temelli, 2009; Fahim et al., 2014; Knez & Weidner, 2003; Yeo & Kiran, 2005).
Moreover, elimination of organic solvents to improve product quality makes SCF another
wonderful candidate for different roles in various applications (Nalawade et al., 2006).
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Figure 2.1. Phase diagram of supercritical fluids.

When processing with SCF, the driving potential for heat and mass transfer is
dictated by the difference from the equilibrium state (Brunner, 2005). The equilibrium
state provides information on: 1) the solvent power (capacity) of a supercritical solvent;
2) the amount of solvent and the equilibrium composition of these phases; 3) the
selectivity of a solvent; and 4) the dependence of solvent properties on conditions of state
(p, T) (Brunner, 2005). If capacity and selectivity are known for a solvent, then a good
guess could be made about whether a separation problem can be solved with SCF
(Brunner, 2005). The solubility of a low volatile substance in SCF (solvent) increases at
constant pressure up to a temperature slightly below the Tc of the solvent; however,
further increase in temperature at “low” pressures (below 100 bar) lead to a decrease in
solubility in SCF. The same dependence of the solubility and temperature higher than Tc
can also be observed. At “low” pressures, solubility decreases with increasing
temperature since density of SCF decreases rapidly with increasing temperature at near-
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critical pressures. Nevertheless, at “high” pressures, density changes with temperature are
far more moderate, and solubility increases with temperature (Brunner, 2005).

2.3.2. Supercritical carbon dioxide (SC-CO2) technology
Among many substances that can be used as SCF, carbon dioxide (CO2) has been
most commonly and widely used in pharmaceutical, chemical and food industries
(Subramaniam et al., 1997). It is a clean and versatile solvent and a promising alternative
to noxious and toxic organic solvents. Since CO2 has a relatively lower critical
temperature and pressure (31.1 °C, 74 bar), it can achieve a more gentle processing
condition, avoiding the degradation of heat liable compounds. In addition, CO2 is a
generally regarded as safe (GRAS) substance, is chemically inert, non-flammable,
inexpensive, and environmental friendly (Ciftci & Temelli, 2014; Vemavarapu, Mollan,
Lodaya, & Needham, 2005; Nalawade et al., 2006). Moreover, many polymers and lipids
possess melting point depression and volumetric expansion in the presence of CO2,
allowing for relatively low temperature processing (Ciftci & Temelli, 2014; Nalawade et
al., 2006). Pressurized CO2 has a substantial impact on the properties of components with
which they are mixed, including increasing solubility, affecting phase behavior,
drastically decreasing the viscosity of condensed phases and surface tension of liquid
which enables mixtures to move freely in small pores and tiny structures (Brunner, 2010).
The solvent power of SC-CO2 can be summarized by a few rules (Brunner, 2005;
Del Valle & Aguilera, 1988): 1) it dissolves non-polar or slightly polar compounds; 2)
the solvent power for low molecular weight compounds is high and decreases with
increasing molecular weight; 3) SC-CO2 has high affinity with oxygenated organic
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compounds of medium molecular weight; 4) free fatty acids and their glycerides exhibit
low solubility; 5) pigments are even less soluble; 6) water has a low solubility (<0.5%,
w/w) at temperatures below 100 °C; 7) proteins, polysaccharides, sugars and mineral
salts are insoluble; and 8) SC-CO2 is capable of separating compounds that are less
volatile, have a higher molecular weight and/or more polar as pressure increases.
SC-CO2 is a good solvent for many non-polar low molecular weight compounds
and a few polymers; but it is a generally very poor solvent for high molecular weight
polymers under controllable conditions (Nalawade et al., 2006).

2.4. Particle formation using supercritical fluid (SCF) technology
SCF, especially CO2, and their potential use for process development have gained
the industries’ interest in the recent decades. SCF have been adopted as a green and
effective alternative to organic solvents to produce particles (Yeo & Kiran, 2005). Some
extraction processes such as decaffeination and extraction of bioactives have already
become commercialized. Particle formation may likely be the next commercialized
application using SCF technology (Yeo & Kiran, 2005).
The unique properties, such as gas-like diffusivities, liquid-like densities,
continuously adjustable solvent power/selectivity and the easiness of complete removal at
the end of the process, make SCF particularly more attractive than conventional methods
including freeze drying, spray-cooling, spray-drying, air micronization, coacervation,
recrystallization from the liquid solution and sublimation, due to it is lack of
contamination of the extracts, residues and environment (Fahim et al., 2014; Thereza,
Gomes, Santos, & Meireles, 2012; Reverchon & Adami, 2006; Hakuta, Hayashi, & Arai,
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2003). In some precipitation methods, organic solvent is completely eliminated, while in
others organic solvent is used, but in greatly reduced amounts, which can be removed
thoroughly due to their high solubility in SCF, therefore avoiding potential of product
contamination (Martín & Cocero, 2008; Hakuta et al., 2003). Several techniques use the
sudden changes of properties by adjusting pressure and temperature to achieve
homogeneous supersaturation, leading to fine powder production with a narrow particle
size distribution (Martín & Cocero, 2008; Priamo et al., 2013; Hakuta et al., 2003). Better
control of particle size, size distribution and morphology can be obtained by SCF
technology than the current methods to form solid lipid particles such as cold HPH and
ultrasonication. Different morphologies can be easily obtained by adjusting process
parameters including pressure, temperature, nozzle diameters, depressurization rate, and
the amount of dissolved CO2 (Nalawade et al., 2006). Furthermore, if a SCF with a
relatively lower critical temperature is used, such as CO2, the process could be conducted
in a mild condition, thus prevent the compounds from thermal degradation (Martín &
Cocero, 2008; Hakuta et al., 2003).
Particle formation using SCF technology can be divided into three groups
depending on their role in the processing: a) SCF as a solvent: Rapid Expansion of
Supercritical Solutions (RESS); b) SCF as a solute: Particles from Gas-Saturated
Solutions (PGSS); and c) SCF as antisolvent: Gas Anti-solvent (GAS), and Supercritical
Anti-solvent (SAS).
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2.4.1. Rapid Expansion of Supercritical Solutions (RESS)
In this process, SCF is a solvent. The active substance is firstly dissolved in a SCF
and becomes saturated at a fixed temperature and pressure, and then a sudden
depressurization takes place in a nozzle, which sprays particles containing active
substance at a high velocity, creating high supersaturation, due to rapid decrease in the
solvent power and temperature (Martín & Cocero, 2008; Hakuta et al., 2003; Priamo et
al., 2013; Fahim et al., 2014).
The advantages of RESS process for fine particle formation include: 1) it allows
high supersaturations which are transmitted rapidly and homogeneously to the whole
fluid, leading to forming particles in small size and narrow size distribution (Martín &
Cocero, 2008); 2) it can be conducted under relatively mild temperature (typically below
80 °C), and is thus suitable for heat sensitive active substance (Martín & Cocero, 2008);
and 3) it eliminates the use of organic solvents (Martín & Cocero, 2008; Fahim et al.,
2014). However, there is a major limitation of the RESS process: it can only apply to
substances with high solubility in the SCF, mainly non-polar compounds or volatile polar
compounds such as ethanol, while non-soluble compounds such as acids could not be
processed (Jung & Perrut, 2001; Reverchon, 1999; Martín & Cocero, 2008).
Additionally, the production capacity may be limited; however, the benefit of elimination
of organic solvent is sacrificed by the addition of a cosolvent to alleviate this problem
(Martín & Cocero, 2008). Furthermore, the extremely fast precipitation could lead to
difficulty in controlling the loading and morphology of the particles (Yeo & Kiran,
2005).
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In the recent two decades, several groups have studied the RESS process for
particle formation, such as pharmaceuticals including carbamazepine (Gosselin, Thibert,
Preda, & McMullen, 2003), griseofulvin (Hu, Johnston, & Williams III, 2004), ibuprofen
(Kayrak, Akman, & Hortacsu, 2003), and functional food compounds such as
phytosterols (Jiang, Chen, & Zhao, 2003; Türk & Lietzow, 2004). Türk and Bolten
(2010) reported the formation of submicron particles of naproxen by using the RESS
process with the particle size in a range of 0.56-0.82 µm. Mishima et al. (2000)
encapsulated protein in polymer. They dissolved protein and polymer both in SC-CO2
with or without a cosolvent. The mixed solution is then depressurized through a nozzle to
form microparticles. Oliveira, Pinto, and Dariva (2005) investigated formation of
polypropylene microparticles from solution mixture with n-butane. They demonstrated
that the concentration of polymer has a profound effect on particle morphology, relatively
lower polymer concentrations favored particle formation with reduced agglomeration.

2.4.2. Particles from Gas-Saturated Solutions (PGSS)
In contrast to RESS, the PGSS process takes advantage of the SCF as a solute
rather than a solvent since the solubilities of compressed gases in liquids and solids are
usually much higher than those of such liquids and solids in the compressed gases (Fahim
et al., 2014; Martín & Cocero, 2008). In the PGSS process, the SCF is firstly dissolved in
a melted solid or a liquid suspended solution, and then the gas-saturated solution is
suddenly depressurized and expanded through a nozzle from supercritical conditions to
ambient pressure, leading to the precipitation of the fine particles as the dissolved SCF
leaves the system in gas form (Željko, 2006; Martín & Cocero, 2008). This process is in
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particular suitable for substances such as polymers, oils and fat, in which SCF not only
has a large solubility but also leads to a considerable reduction in melting point, viscosity
and interfacial tension (Martín & Cocero, 2008; Fahim et al., 2014; Martín & Weidner,
2010; Weidner, 2009). Again, the driving force is the sudden pressure drop and intense
cooling effect produced by the escape of SCF. PGSS process can only be applied to
substances for which the antisolvent effect of SCF is small, because otherwise, the solute
would precipitate and not expand in the vessel (Martín & Cocero, 2008).
The advantages of PGSS process for particle formation include: 1) low SCF
consumption and a reduced operating pressure due to the high solubility of SCF in melted
solid or liquid suspended solution (Priamo et al., 2012; Jung & Perrut, 2001); 2)
elimination of organic solvents (Tabernero, Del Valle, & Galán, 2012); 3) lower cost
compared to other processes (Fahim et al., 2014), and 4) ease of adaptation to large scale
production (Yeo & Kiran, 2005). However, the major disadvantage of PGSS process is
the difficulty producing submicron-sized particles and poor control of particle size
(Fahim et al., 2014; Weidner, 2009).
Up to date, more than 100 substances have been powderized with the PGSS
process, including polymers, waxes and resins, natural products (extracts from spices,
phospholipids, methanol) and fat derivatives (fatty acids, diglycerides, fatty alcohols,
cocoa butter) (Weidner, 2009; Münüklü, 2005; Jung & Perrut, 2001). The atomization in
the PGSS process can be improved by using a second gas such as air as an addition in the
expansion vessel, generating the Gas-assisted Melting Atomization process (GAMA)
(Salmaso, Elvassore, Bertucco, & Caliceti, 2009). Another application of the PGSS
process is PGSS-drying, which dries aqueous solution into powder form (Priamo et al.,
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2012; Thereza et al., 2012). This technique promotes the mass transfer between the SCF
and the aqueous solution, and then the mixture is depressurized (Tabernero et al., 2012).
Recently, Varona, Kareth, Martín, and Cocero (2010) used this technique to encapsulate
lavandin oil in starches by removing water from an O/W emulsion stabilized with Noctenyl succinic anhydride starches as surfactants. Gitin, Varona, and Cocero (2011)
encapsulated garlic essential oil by PGSS process where polyethylene glycol (PEG) was
used as a carrier. They reported that the particle size was within 71-206 µm, and the
encapsulation efficiency was 26-49%.

2.4.3. Gas Anti-solvent (GAS)
GAS is devised to recrystallize solid materials that are not soluble in SCF
(Tabernero et al., 2012). The SCF is used in batch mode in this process (Yeo & Kiran,
2005; Fahim et al., 2014). The technique is especially suitable for polymers and fats and
oils because most them are not soluble in SCF or gases (Yeo & Kiran, 2005). The molten
solid is firstly dissolved in conventional liquid organic solvent as in SAS, and the
solution is then introduced into the SCF from the bottom by a filter by a disperser, at a
predetermined constant rate and temperature, leading to a rapid volume expansion of
organic solvent (Fahim et al., 2014; Martín & Cocero, 2008; Yeo & Kiran, 2005;
Franceschi et al., 2008). As a result, the solvent power of the conventional organic
solvent decreases and supersaturation in which the gas concentration in solution increases
with pressure and in turn causes precipitation of the particles (Fahim et al., 2014; Martín
& Cocero, 2008; Yeo & Kiran, 2005). In this process, the antisolvent gas does not have to
be at supercritical condition (Yeo & Kiran, 2005). After the solute material has
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completely precipitated out, fresh antisolvent SCF or gases is used to flush the system to
remove away the solvent (Jung & Perrut, 2001; Yeo & Kiran, 2005).
The advantages of GAS process include: 1) ability to load a large amount of
solute material at one time; 2) flexibility in choosing organic liquid solvent that has less
operational problems compared to other techniques; and 3) the potential to obtain
solvent-free particles in micron and submicron sizes (Fahim et al., 2014; Knez &
Weidner, 2003; Silva & Meireles, 2014). However, the major drawback is the possible
toxic solvent residue (Fahim et al., 2014; Knez & Weidner, 2003; Silva & Meireles,
2014). Moreover, there is a lack of control over particle size, which prevents the
formation of mono dispersed particles (Fahim et al., 2014).
Some of the most remarkable applications among varieties of materials processed
with SC-CO2 as antisolvent are pharmaceuticals, polymers, superconductor precursors,
and natural substances and colorants (Martín & Cocero, 2008). Kim et al. (2011) formed
cyclotetramethylenetetranitramine particles using GAS process, and the particle size was
within 1-133 µm. However, studies that address the mechanism and kinetics of particle
formation in the GAS process are scarce (Martín & Cocero, 2008).

2.4.4. Supercritical Anti-solvent (SAS)
In SAS process, SCF acts as an antisolvent, saturates the liquid solvent that
reduces the solubility of a solute dissolved into a conventional liquid solvent, resulting in
precipitation of solute. Due to the phase behavior of SCF with many solvents, the
solution expands and its viscosity is reduced, and therefore solubility of the active
substance in the liquid phase decreases (Fahim et al., 2014; Hakuta et al., 2003). Upon
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depressurization, the expanded solution becomes supersaturated, thus forcing the active
substance to deposit as micron-sized particles (Hakuta et al., 2003; Reverchon, Adami,
Caputo, & De Marco, 2008). There are different types of SAS techniques where the
substance is firstly dissolved in a conventional solvent (dichloromethane, methanol,
ethanol, dimethylsulfoxide, etc.) and then leads to the precipitation of the particles
(Fahim et al., 2014). Indeed, SAS process is a modified GAS process in a continuous or
semi-continuous operation.
The advantages of SAS process include: 1) it controls of the particle morphology
on a very wide range from nanoparticles to microparticles; 2) is amenable to continuous
processing which is suitable for large scale production of micro- and nanoparticles; and
3) freshly precipitated particles can be easily collected and the SCF with organic solvent
can be drained continuously from the system (Fahim et al., 2014). Nevertheless, the
major limitation of SAS process is the usage of organic solvents which may have toxic
residual solvent in the final product (Fahim et al., 2014). In addition, longer washing
period is required due to agglomeration and aggregation of the particles in the nozzle
(Jung & Perrut, 2001; Yeo & Kiran, 2005; Byrappa, Ohara, & Adschiri, 2008).
The use of SCF as antisolvent can usually be performed at pressure lower than
100 bar and temperature slightly above the Tc of SCF. Falk, Randolph, Meyer, Kelly, and
Manning (1997) produced composite microspheres by the SAS process. In their study, a
homogeneous solution of the solutes and polymers were sprayed, thus co-precipitation of
polymers and solutes occurred where both composite microspheres and microcapsules
were formed. Young, Johnston, Mishima, and Tanaka (1999) produced the lysozyme
with a biodegradable polymer by precipitating with a vapor-over-liquid antisolvent, and
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the obtained particles were in a range of 1-10 µm. There are only few reports on the use
of GAS for food and food ingredients. Generally, SAS process has been demonstrated to
have industrial potential not only for drugs or polymers, but also for food applications
(Weber, Beutin, Tschernjaew, & Kummel, 1997; Rantakylä, 2004; Thiering, Dehghani,
& Foster, 2001).

2.5. Lipid particle formation using supercritical carbon dioxide (SC-CO2)
The need for incorporation of lipophilic bioactive compounds into food and
beverages to improve bioactive solubility and bioavailability, leading to improved food
quality and health benefits, has led the development of lipid-based particle formation in
food industry. Lipids are promising delivery vehicles for lipophilic bioactives due to their
biocompatibility and enhanced absorption (Dolatabadi et al., 2015; Severino et al., 2012).
Contrary to larger lipid particles, micro- and nano- lipid particles could help prevent
separations of bioactives from solidifying lipid matrix and bioactives can be evenly
dispersed in the matrix, therefore maintaining integrity in case of degradation due to
thermal or mechanical stress (Müller et al., 2002). In addition, because of the extremely
small size, nanocarriers have shown advantages including improvement of the aqueous
solubility, enhancement of residence time in GI regions, better physicochemical stability
in GI tract, intracellular delivery and transcellular delivery (Oehlke et al., 2014).
The utilization of solid lipids rather than liquid oils has advantages of achieving
controlled bioactive release and bioactive stability against thermal and mechanical stress
(Dolatabadi et al., 2015; Scalia, Young, & Traini, 2015), thus SLN have become one of
the most promising lipid-based delivery system for bioactives and drugs. Nevertheless, to
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some extent, current conventional methods producing SLN have restricted the full
potential of developing an efficient delivery system. Safety concerns due to solvent use in
solvent emulsification/evaporation method; bioactive instability in hot homogenization
and high shear homogenization methods, and potential metal contamination and particle
physical instability in ultrasonication method are the limitations of the current methods
(Beh, Mammucari, & Foster, 2012; Ekambaram et al., 2012).
SC-CO2 technology could address these problems by decreasing the melting
temperature of the solid lipids, thus making particle formation under moderate conditions
to process heat sensitive bioactives (Ciftci & Temelli, 2014). SC-CO2 has a substantial
impact on the properties of components with which they are mixed, including increasing
solubility, affecting phase behavior, drastically decreasing the viscosity of condensed
phases and surface tension of liquid (Brunner, 2010), thus used to optimize process
parameters to generate ideal particles with preferred size and morphology (Hakuta et al.,
2003; Knez & Weidner, 2003; Nalawade et al., 2006; Mishima, 2008). Moreover,
increasing operating pressure within a specific range under the critical low temperature
obtained by melting study could enhance the solubility of either CO2 or lipids in the other
one, which in turn affect the supersaturation of the solute in the solvent and the mass
transfer of that solvent, which are both substantial for micronization and formation of
composite particles (Yasuji, Takeuchi, & Kawashima, 2007).
Understanding the melting behavior of solid lipids in pressurized CO2 is
important for the production of solid lipid particles using SC-CO2 (Ciftci & Temelli,
2014). Fundamentals concerning melting point depression, phase behavior and
volumetric expansion have been explored to design particle formation process for
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controlling the micronization (Knez & Weidner, 2003). Salmaso et al. (2009) reported
that the melting temperature of the protein lipid mixture decreased to 35-40 °C under 150
bar CO2 pressure. Moreover, Ciftci and Temelli (2014) reported a positive correlation
between the melting point depression and volumetric expansion of the solid lipids in
pressurized CO2.
Lipid particle formation using SC-CO2 is a fairly new research area. Badens,
Magnan, and Charbit (2001) formed microparticles with size ranging from 1 to 40 μm
from soy lecithin by the SAS process with ethanol as cosolvent. Using the same SAS
process, Kunastitchai, Pichert, Sarisut, and Müller (2006) generated liposomes in a dry
and reconstitutable form. In addition, Dos Santos, Richard, Pech, Thies, and Benoit
(2002) coated protein particles of BSA with two commercial lipids, either Gelucire® 5002 or Dynasan® 114, by depressurizing the suspension of BSA particles in SC-CO2
solution of lipids. Gelucire® 50-02 consisted of a mixture of glycerides and fatty acid
esters, whereas Dynasan® 114 only had trimyristin. The protein release of the particles
coated with both lipids were more controllable than that of the uncoated protein.
However, particles coated with trimyristin experienced an initial burst release of about
70% in 30 min at 37 °C due to the crystallization, leading to a rather homogeneous
coating, whereas a prolonged release has been achieved over a 24 h period from particles
coated with Gelucire® 50-02. Moreover, Mandžuka and Knez (2008) determined the
Solid-Liquid-Gas equilibrium data in 50-600 bar for monostearate/CO2 and
tristearate/CO2, and formed particles using batch PGSS micronization. Micronizations of
monostearate and tristearate were performed in pressure range of 60-210 bar at 70 and 80
ºC, and at 60 and 70 ºC, respectively. The average size of monstearate and tristearate
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particles were 10-40 µm depending on pre-expansion pressure and temperature. Particles
after micronization had irregular and porous shape. Polymorphic form remained the same
but the degree of crystallinity for both was lower when compared to original samples.
Using SCF assisted emulsion/diffusion method, which was proposed to improve the
classical emulsification/diffusion by the addition of a continuous SCF processing step to
eliminate organic solvent, Campardelli et al. (2013) produced lipid nanoparticles of
stearic acid. They tested different formulations for stearic acid nanoparticles and
processed by supercritical continuous extraction at 80 bar and 25 ºC/or 45 ºC (liquid/gas
ratio of 0.1). The mean particle size was 33 and 41 nm, respectively, achieving one order
of magnitude smaller than the ones obtained by conventional emulsion/diffusion method,
and the supercritical flow did not damage the particles. Similar to the PGSS process,
supercritical melting micronization (ScMM) process was adopted by Lubary, De Loos,
Ter Horst, and Hofland (2011) to produce microparticles from milk fat. Both anhydrous
milk fat (AMF) and a diacylglycerol-based modified milk fat (D-AMF) had the ability to
dissolve 30% (w/w) CO2 in up to 130 bar and 25-70 ºC, and melting point depression was
observed in both systems with pressurized CO2. The AMF particles were composed of
mainly the β’ polymorph, regardless of morphology, whereas D-AMF seemed to
crystallize predominately as α polymorph. Furthermore, Bertucco, Caliceti, and Elvassore
(2007) reported a similar process for the formation of SLN using Gas-assisted Melting
Atomization (GAMA). In their process, molten mixture was pressurized with CO2, and
then a semisolid or liquid mixture was created with a second gas (air) which did not
completely dissolve into the mixture, and then the mixture was expanded with
evaporation of CO2 to form solid lipid micro- and nanoparticles.
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SC-CO2 technology, specifically the PGSS process, has been reported to achieve
loading of lipophilic bioactives in the solid lipid particles (Salmaso et al., 2009; Vezzù et
al., 2010). Pedro et al. (2016) produced curcumin-loaded solid lipid particles by the
PGSS technique. The lipid matrix studied was tristearin + soy phosphatidylcholine
(PC)/dimethylsulfoxide (DMSO) + curcumin, with ratios from 65.6:1 to 3:1. The loading
yield was found to be in the range of 30-87% (w/w) drug/lipid. Curcumin-loaded solid
lipid particles were more homogeneous in size with low DMSO feed, whereas the
formulation with the highest DMSO feed yielded a bimodal particle size distribution with
significant aggregation. The PGSS process was found to be properly set-up to produce
solid lipid particles without degrading drugs. De Paz, Martín, and Cocero (2012a)
formulated β-carotene with soybean lecithin by PGSS-drying process. They firstly
prepared organic-on-water β-carotene emulsions and aqueous β-carotene suspensions,
and then precipitated the lecithin by PGSS-drying to obtain the β-carotene-encapsulated
lecithin particles. The particle size ranged from 10-500 µm, constituted by fused
spherical particles less than 10 µm. The encapsulation efficiency was up to 60%. By
hydrating these particles, β-carotene-loaded multilamellar liposomes of 1-5 µm were able
to be obtained. In the same year, the same group formulated β-carotene with poly-(εcaprolactones) by PGSS process (De Paz, Martín, Duarte, & Cocero, 2012b). The particle
size was in the range of 270-650 µm with a β-carotene content up to 340 ppm when using
polycaprolactone with molecular weight of 10000 g/mol, whereas the decreased to 110130 µm when using polycaprolactone with molecular weight of 4000 g/mol. They also
investigated the effects operating conditions on the particle formation. Bigger particles
were obtained when the pressure and temperature were 150 bar and 50 ºC, compared to
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the particles obtained at 110 bar and 70 ºC. Moreover, García-González et al. (2010)
investigated the encapsulation efficiency of solid lipid hybrid particles prepared using the
PGSS technique and loaded with different polarity active agents. The lipid hybrid
contained a glyceryl monostearate (Lumulse® GMS-K), and a waxy triglyceride (Cutina®
HR). All experiments were performed at 130 bar and 71 °C based on the previous
measurements of lipid melting points. Solid lipid particles were loaded with silanized
TiO2 and caffeine, glutathione or ketoprofen in 6-7% (w/w) for the mineral filler and 4.5,
5.6 and 16.1% (w/w) for the active agents. They found that hydrophilic drugs, such as
caffeine and glutathione, had a limited interaction with the lipophilic matrix and thus a
limited capacity to be encapsulated. On the contrary, hydrophobic ketoprofen was
entrapped in the lipidic particles as a molecular dispersion, and this formulation can be
used for a sustained release (t2h = 20%). Furthermore, Sampaio de Sousa, Simplício, De
Sousa, and Duarte (2007) produced caffeine-loaded solid lipid particles of glyceryl
monostearate using the PGSS technique at 130 bar and 61 °C and had a mean particle
size D[3,2] of 5.49 µm. The particles were loaded with 140 mg of caffeine/g particle.

2.6. Conclusions
Development of bioactive-carriers to improve the solubility, stability and
bioavailability of lipophilic bioactives has become a target for food industry to produce
health and wellness promoting foods and beverages. Lipids are especially preferred in
formulation of dietary controlled delivery systems, due to their biocompatibility,
enhancement of the absorption of bioactive in the GI tract, and targeted delivery.
Production of the bioactive-carrier hollow solid lipid micro- and nanoparticles using SC-

43

CO2 is a relatively new area. Hollow solid lipid micro- and nanoparticles have the
advantages of SLN such as better protection of the loaded bioactive but higher loading
capacity and minimized or no bioactive expelling due to hollow structure using a simple
and green process.
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CHAPTER 3. FORMATION OF HOLLOW SOLID LIPID MICRO- AND
NANOPARTICLES USING SUPERCITICAL CARBON DIOXIDE*

3.1. Abstract
Hollow solid lipid micro- and nanoparticles were formed from FHSO using
atomization of the carbon dioxide (CO2)-expanded lipid. Melting point of FHSO
decreased from 68.5 °C to 57 °C (0.096 °C/bar) above 120 bar in pressurized CO2.
Processing conditions of 50 µm nozzle diameter and 200 bar CO2 pressure yielded
smaller (d50% = 278 nm) hollow solid lipid particles. Increasing nozzle diameter and
pressure affected the particle morphology and size negatively. Shell thickness of the
particles decreased with increasing pressure at the same nozzle diameter. Decreasing the
nozzle diameter yielded the polymorphism of the particles from β to α. Melting point of
the particles shifted to a lower melting range and broadened the melting range compared
to FHSO. The results showed that the reported supercritical CO2-assisted atomization
process is a promising method to form hollow solid lipid micro- and nanoparticles to
develop bioactive delivery systems.
Keywords: Nanoparticle; Supercritical carbon dioxide; Lipid; Melting; Oil

3.2. Introduction
The growing demand for “natural” and “clean” products along with the increase
in the prevalence of diet-related illnesses such as obesity, type-2 diabetes, cardiovascular
disease and cancer have led the food industry prioritize the development of health and
* This chapter has been published. Yang, J., & Ciftci, O. N. (2016). Formation of hollow solid lipid microand nanoparticles using supercritical carbon dioxide. Food and Bioproducts Processing, 98, 151-160.

58

wellness promoting foods by incorporating bioactive components into foods and
beverages. Many researches have verified that by incorporating functional ingredients
into consumers’ daily diet could have a significant positive effect on health promotion as
well as relief of the above-mentioned illnesses (Qin et al., 2004; Shu et al., 2009;
Bradford & Awad, 2007). However, many bioactives are lipophilic, resulting in poor
water solubility that requires extra processes such as emulsification to make their addition
into water possible, and result in poor absorption through gastrointestinal tract and
limited bioavailability due to various physiochemical transformations during digestion
(Ting et al., 2014). In addition, many of these bioactives are chemically sensitive, prone
to degrade or decompose when exposed to light, oxygen, and heat during processing and
storage. Therefore, inclusion of lipophilic bioactives in foods and beverages to produce
functional foods and beverages has been a main challenge in the food industry.
Lipids are promising delivery vehicles for lipophilic bioactives due to their
biocompatibility and enhanced absorption (Dolatabadi et al., 2015; Severino et al., 2012).
The utilization of solid lipids rather than liquid oils has the advantages of achieving
controlled bioactive release and bioactive stability against thermal and mechanical stress
(Dolatabadi et al., 2015; Scalia et al., 2015), thus solid lipid nanoparticles (SLN) have
become one promising lipid-based delivery system for bioactives and drugs.
Nevertheless, to some extent, drawbacks of the SLN and their conventional production
methods have restricted the full potential of developing an efficient delivery system.
Safety concerns due to solvent use in solvent emulsification/evaporation method;
bioactive instability in hot homogenization and high shear homogenization methods, and
potential metal contamination and particle physical instability in ultrasonication method
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are the limitations of the current methods (Beh et al., 2012; Ekambaram et al., 2012).
Moreover, SLN possess poor loading capacity, and also may expel the loaded bioactive
during crystallization, because it is a full solid lipid particle (Mukherjee, Ray, & Thakur,
2009).
A promising strategy to overcome above-mentioned problems in manufacturing
fine solid lipid particles can be realized by using supercritical fluid technology, which has
been considered as an effective and green alternative to process materials in the
pharmaceutical, chemical and food industries (Subramaniam et al., 1997; Fahim et al.,
2014; Campardelli et al., 2013). Among many substances that can be used as supercritical
fluid, CO2 is the most common one since it has a relatively mild critical temperature and
pressure (31 °C, 74 bar), and also it is nontoxic, nonflammable, environmental friendly,
cheap, and safe. SC-CO2 has a substantial impact on the properties of components with
which they are mixed, including increasing solubility, affecting phase behavior,
drastically decreasing the viscosity of condensed phases and surface tension of liquid
(Brunner, 2010), thus serving as the most important phenomenon used to optimize
process parameters to generate ideal particles with preferred size and morphology
(Hakuta et al., 2003; Knez & Weidner, 2003; Nalawade et al., 2006; Mishima, 2008).
Though have been recognized as an efficient alternative to liquid oils and/or
colloidal systems, the potential of solid lipid carrier systems for food applications has not
yet been fully explored. In this study, we investigated the formation hollow solid lipid
micro- and nanoparticles that can be used as bioactive-carrier systems using SC-CO2
technology. The hollow structure can increase the loading efficiency significantly
compared to SLN, and solve the bioactive expelling problem. There are few reports on
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the formation of solid lipid particles using supercritical fluid technology reporting
formation of only microsize particles using the Particles from Gas-saturated Solutions
(PGSS) technique (Sampaio de Sousa et al., 2007; Mandžuka & Knez, 2008; GarcíaGonzález et al., 2010; Lubary et al., 2011). Previously, Bertucco et al. (2007) reported a
similar process for the formation of SLN using a similar process Gas-assisted Melting
Atomization (GAMA). In their process, molten mixture was pressurized with CO2, and
then a semisolid or liquid mixture was created with a second gas (air) which did not
completely dissolve into the mixture, and then the mixture was expanded with
evaporation of CO2 to form solid lipid micro- and nanoparticles (Bertucco et al., 2007).
Production of solid lipid submicron particles for protein delivery (Salmaso et al., 2009)
and bioactive-containing solid lipid microparticles (Vezzù et al., 2010) were also
reported. To the best of our knowledge, there is no report on the formation of hollow
solid lipid particles at both micro- and nanosize using SC-CO2.
The main objective of this study was to form hollow solid lipid micro- and
nanoparticles (nanospheres) from fully hydrogenated soybean oil (FHSO) that will be
used as biocompatible lipophilic bioactive delivery systems using SC-CO2. The specific
objectives were to investigate the effects of pressure and nozzle diameter on the particle
morphology, size and size distribution, melting properties, and polymorphism.

3.3. Materials and methods
3.3.1. Materials
FHSO was kindly provided by ConAgra Foods Inc. (Omaha, NE, USA). CO2
(99.99% purity) was purchased from Matheson (Lincoln, NE, USA).
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3.3.2. Determination of melting behavior of the FHSO in pressurized CO2
Melting behavior of the FHSO in pressurized CO2 was studied according to Ciftci
and Temelli (2014) in a jacketed high pressure vessel equipped with two sapphire
windows, microscope and camera systems, refrigerated circulator (model 1162A, VWR
Inc., Radnor, PA, USA). The temperature of the vessel was controlled by circulating
water through the jacket of the vessel. The molten FHSO was placed into a glass gas
chromatograph vial insert (200 µL) between two windows, then the vessel with CO2
pressurized using a syringe pump (Model 250D, Teledyne Isco Inc., Lincoln, NE, USA).
After 1 h stabilization time, the temperature of the vessel was decreased to 5 °C below
the solidification temperature of the FHSO that was observed via the microscope-camera
system. Then, the temperature of the vessel was increased at a rate of 0.3 °C/min until
first melting of the sample was observed. The melting temperature and pressure of the
lipid under pressurized CO2 was recorded as the pressure and temperature at which the
first melting was observed.

3.3.3. Production of hollow solid lipid micro- and nanoparticles using SC-CO2
The hollow solid lipid particles were produced from FHSO using the particle
formation system shown in Figure 3.1. The system consisted of a high-pressure syringe
pump, pre-heating section, 100 mL high-pressure expansion vessel, magnetic drive,
magnetic drive controller, pressure gauge, thermocouple, sampling port, rupture disk,
depressurization valve, and nozzle. The expansion vessel, depressurization valve, and
nozzle were heated with heating tapes, and digital temperature controllers were used to
control temperature of the heating tapes. Temperature of the expansion vessel was

62

maintained at 57 °C that is the melting point of FHSO under CO2 at 120 bar. Temperature
of the depressurization valve and nozzle was set to 5 °C above the melting point of the
FHSO under atmospheric conditions.

Figure 3.1. Schematic diagram of the particle formation unit. (1) CO2 cylinder; (2)
needle valve; (3) high pressure syringe pump; (4) pre-heating section; (5), (6), (8)
temperature controller; (7) CO2 inlet valve; (9) 100 mL high pressure expansion vessel;
(10), (18) heating tape; (11) magnetic drive; (12) thermocouple; (13) pressure gauge; (14)
magnetic drive controller; (15) sample inlet port; (16) rupture disc; (17) depressurization
valve; (19) CO2 exhaust; (20) sample collection vessel.

The FHSO sample was firstly melted on a heater at 130 °C and then 20 mL of
molten FHSO was injected into the expansion vessel through the sampling port. Then, the
CO2 inlet valve was slowly opened, and the expansion vessel was pressurized with CO2
with the syringe pump until the set pressure was reached. The magnetic drive was turned
on at 1000 rpm to mix the pressurized CO2 and the FHSO to obtain the maximum
expansion of SC-CO2-dissolved solid lipid for 1 h. Then, the magnetic drive was turned
off and waited for 10 min for stabilization of the SC-CO2-expanded solid lipid. The
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pressure of the syringe pump was set to 10 bar above the pressure of the expansion
vessel, and CO2 inlet valve was opened, then depressurization valve was opened. Upon
opening depressurization valve, CO2-expanded lipid was atomized through the nozzle,
solid lipid particles were formed and collected in the sample collection vessel, and CO2
left the system in the gas form. During atomization, the pressure in the expansion vessel
stayed constant due to continuous feeding CO2 into the vessel.

3.3.4. Determination of the particle size and size distribution
Particle size and size distribution of the samples were measured using a laser
diffraction particle size analyzer (Mastersizer 3000, Malvern Instruments Ltd.,
Worcestershire, UK). Samples (30 mg) were dispersed in 25 mL distilled water
containing 0.4% (w/w) of Tween 80. Suspensions were sonicated in an ultrasonic water
bath (3510 R-MTH, Branson Ultrasonics Corporation, Danbury, CT, USA) for 30 min
before each analysis. The refractive index (RI) of the material was set as 1.46 with
distilled water (RI = 1.33) as dispersant. The obscuration value was in the range of 5% 7% for each analysis.

3.3.5. Determination of the particle morphology
Morphology of the obtained particles was analyzed by using a Field EmissionScanning Electron Microscope (FE-SEM) (S4700, Hitachi High-Technologies
Corporation, Japan). A thin layer of the sample was placed onto a sample mount using
double-sided carbon tape and sputter coated with chromium using a HiPace 80 (Pfeiffer
Vacuum, Germany) in argon atmosphere.
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Morphology of the filtered nanoparticles obtained at 50 µm nozzle diameter and
200 bar was analyzed using a Transmission Electron Microscopy (TEM) (H7500, Hitachi
High-Technologies Corporation, Japan). Drops of 2% (w/w) suspension dispersed in
water after filtration were deposited on a carbon-coated copper grid (200 mesh) and
negatively stained with 2% uranyl acetate solution, and waited to dry before examination.

3.3.6. Separation of the nanoparticles from microparticles
Samples (30 mg) were dispersed in 25 mL distilled water containing 0.4% (w/w)
of polyoxyethylene sorbitan monooleate (Tween 80). Suspensions were sonicated in an
ultrasonic water bath (3510 R-MTH, Branson Ultrasonics Corporation, Danbury, CT,
USA) for 30 min. Then, the suspension was filtered through 0.45 μm pore size syringe
filter. The filtrate was analyzed for the particle size and size distribution and morphology
as described in Sections 3.3.3. and 3.3.4., respectively.

3.3.7. Determination of the melting profile
Melting profile of the obtained particles was determined using a Differential
Scanning Calorimeter (DSC) (Pyris 1, Perkin Elmer, Waltham, Massachusetts, USA).
The samples (5-7 mg) were placed and hermetically sealed in a stainless steel pan with an
O-ring attached. An empty sealed pan was used to serve as a reference. The pans were
placed in the calorimeter and equilibrated at 25 °C for 1 min. The samples were heated
from 25 °C to 100 °C at a heating rate of 5 °C/min to observe the fusion of the particles.
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3.3.8. Determination of the polymorphism
The polymorphism of the obtained lipid particles was determined using
PANalytical Empyrean Diffractometer (XRD) unit (Empyrean, PANalytical,
Westborough, MA, USA), operated with Cu Kα radiation at a voltage of 40 kV and
intensity of 45 mA. A mask of 20 mm and a divergence slit of 1/4 degree were used on
the incident beam path. Before XRD analysis, the powder samples were filled in 27 mm
diameter, 2 mm deep pockets of stainless steel holders and the surface was levelled. A
15-position, automatic sample exchanger was used to measure the batch of samples. The
sample holders were continuously spun at the rate of 22.5 deg/s during the measurement.
Samples were run from 2 to 50 degrees under continuous scan at 2θ min-1 with a step size
of 0.026, and a diffracted beam monochromator for the PIXcel detector was utilized to
improve the signal to noise ratio.

3.4. Results and discussion
Expansion of the lipids under pressurized CO2 due to the solubility of the CO2 in
the lipids is the key to the formation of micro- and nanoparticles using atomization of
CO2-expanded lipid mixtures. Previously, it was shown that solid lipids expand when
mixed with pressurized CO2, and melting point of the lipids decrease significantly in
pressurized CO2 (Ciftci & Temelli, 2014). Therefore, it is crucial to conduct a separate
study to determine the melting point of the lipid that will be used for particle formation
using the atomization of CO2-expanded lipid method. Melting point of the FHSO in
pressurized CO2 was determined (Fig. 3.2), and the obtained melting temperature of the
FHSO in the pressurized CO2 was used as the temperature in the particle formation
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experiments. Melting point of FHSO at atmospheric conditions was 68.5 °C; however, it
decreased to 57 °C above 120 bar under pressurized CO2 (Fig. 3.2). Melting temperature
of 57 °C was the lowest temperature that FHSO will melt under pressurized CO2;
therefore, 57 °C was used for all particle formation experiments. Pressure range used in
the particle formation experiments started from the lowest pressure (120 bar) where the
lowest melting point of the FHSO (57 °C) was obtained (Fig. 3.2). Melting point
depression in pressurized CO2 is important; a lower temperature will be used to keep the
lipid and bioactive mixture in the liquid state, and lower process temperatures will enable
us to minimize the degradation of the heat sensitive bioactives when lipid and bioactive
are mixed to obtain bioactive-loaded lipid particles.
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Figure 3.2. Melting point depression of fully hydrogenated soybean oil (FHSO) in
pressurized CO2.
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3.4.1. Effect of particle formation conditions on the particle morphology
Figure 3.3 shows the effect of particle formation conditions (nozzle diameter and
pressure) on the morphology of the lipid particles. Nozzle diameter and pressure was
critical to control the morphology of the lipid particles. Hollow solid lipid particles were
successfully obtained with 50 μm nozzle diameter at all studied pressures (120, 200, and
300 bar). Increasing nozzle diameter affected the particle morphology negatively;
particles lost their spherical shape and smooth surface at 75 and 100 μm nozzle diameters
at all studied pressures. It was targeted to obtain spherical particles because spherical
shape provides homogenous mixing during product formulation, and more controlled
release of the bioactives (Mu & Feng, 2003). Solubility of CO2 in the molten lipid was
the key phenomena for the particle formation by atomization of the SC-CO2-expanded
FHSO. Upon pressurization with SC-CO2, liquid FHSO expanded due to dissolution of
the CO2 in the lipid phase. Volumetric expansion of the lipids is a function of CO2
solubility in the lipid phase (Jenab & Temelli, 2012), and recently Ciftci and Temelli
(2014) reported the volumetric expansion of various solid lipids (fully hydrogenated
canola oil, cocoa butter, coconut oil, tristearin, trilaurin, monostearin, stearic acid, lauric
acid) in pressurized CO2.
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Figure 3.3. Scanning electron microscopy (SEM) images showing the effect of the
particle formation conditions on the particle morphology.

Ciftci and Temelli (2014) showed that degree of the volumetric expansion of the
solid lipids due to dissolution of the CO2 in the lipid phase depends of the fatty acid
composition (chain length) of the lipid; it increases up to a certain level with increasing
pressure but then reaches a plateau. They reported that fully hydrogenated canola oil,
which is very similar to FHSO in terms of fatty acid composition (88% stearic acid)
expands by 9.7%, reaches plateau at 122 bar, and further increase in the pressure does not
increase the volumetric expansion further, meaning the concentration of the CO2 in the
lipid phase does not change after 122 bar. Based on the findings of Ciftci and Temelli
(2014), the amount of the CO2 in the expanded FHSO above 120 bar was constant, and
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this was supported by the decrease in the melting point of the FHSO in pressurized CO2
up to 120 bar and staying constant above 120 bar (Fig. 3.2). The proposed mechanism of
hollow solid lipid particle formation using the atomization of the CO2-expanded lipid is
presented in Figure 3.4. Upon atomization of the CO2-expanded lipid through the nozzle,
small droplets of lipid and CO2 mixture were formed. Due to pressure drop, CO2 in the
atomized liquid lipid expanded, and the atomized lipid formed a spherical denser shell.
During CO2 expansion, cooling at the nozzle and surrounding area took place due to
Joule-Thompson effect. The dense lipid shell formed by the expansion of CO2 solidified
when contacted with the cold environment, and formed the hollow spherical solid lipid
particles. Both pressure and nozzle diameter played critical role in the formation of
spherical hollow lipid particles. At higher pressures and bigger nozzle diameters (100
μm), the size of the atomized lipid + CO2 droplet was bigger and there was more CO2
dissolved in the lipid droplet, and this caused a more powerful CO2 expansion that broke
the particles. However, nozzle with 50 μm diameter formed smaller droplets of lipid and
CO2 mixture; smaller droplets contained smaller amount of CO2; therefore, expansion of
the CO2 was less powerful, which resulted in unbroken spherical hollow solid lipid
particles. Pressure was critical to control the shell thickness of the particles. SEM images
showed that the shell thickness of the lipid particles decreased with increasing pressure
(Fig. 3.5). At higher pressure (300 bar), a bigger force was exerted onto the forming
liquid lipid shell during CO2 expansion in all directions; therefore, the diameter of the
lipid shell was bigger and the thickness of the liquid shell was smaller when the
solidification took place.
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Figure 3.4. Proposed mechanism of the hollow solid lipid particle formation using
atomization of CO2-expanded lipid.

Shell thickness determines the volume in the hollow particle, in turn loading
capacity, and also the strength of the particles. Moreover, shell thickness is important for
the protection of the loaded bioactive and its release properties. Thinner shells will result
in bigger inner volume; however, the particles may be fragile. Figure 3.5 shows the SEM
images of the selected particles that were broken to show the hollow structure. As shown
in Figures 3.5a and 3.5b, increasing the pressure from 120 to 300 bar using the 50 μm
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nozzle diameter decreased the shell thickness and made the particles fragile. Similarly,
increasing the pressure from 120 to 200 bar using 75 μm nozzle diameter decreased the
shell thickness; however, the particles were not fragile due to presence of more lipid to
form the shell (Figs. 3.5c and 3.5d). The particles obtained with 50 μm nozzle diameter at
200 bar were intact hollow solid lipid particles and they were not damaged during
handling.

a

b

40 µm

5 µm

c

d

5 µm

2 µm

Figure 3.5. Scanning electron microscopy (SEM) images of the broken hollow solid lipid
particles. (a) 120 bar, 50 μm nozzle; (b) 300 bar, 50 μm nozzle; (c) 120 bar, 75 μm
nozzle; (d) 200 bar, 75 μm nozzle.

3.4.2. Effect of processing conditions on the particle size
Figure 3.6 presents the size distribution of the lipid particles obtained with
different nozzle diameters (100, 75 and 50 µm) and pressures (120, 200, and 300 bar).
Nozzle diameters of 75 and 100 μm formed particles with similar size; whereas, 50 μm
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nozzle diameter formed smaller particles at 200 and 300 bar because smaller nozzle
diameters generated smaller lipid droplets containing smaller amount of lipid and
compressed CO2. Size distribution of the particles obtained using nozzle diameters of 75
and 100 μm was unimodal at 120 bar, whereas they were bimodal at 200 and 300 bar.

Figure 3.6. Effect of the particle formation conditions on the size distribution of the
hollow solid lipid particles.

Size distribution of the particles obtained using nozzle diameters of 50 μm was
bimodal at all pressures. It should be noted that the pieces of the broken particles may
cause smaller particle size resulting at high pressures; therefore, it is important to
evaluate the morphology of the particles with SEM. Figure 3.6 shows that fifty percent
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(d50%) of the particles obtained with 100 μm at 300 bar was smaller than 28.6 nm;
however, SEM images showed that the small size distribution was primarily due to the
presence of the pieces of the broken particles. Based on the particle size data and
morphology of the particles, processing conditions of 50 μm and 200 bar was found to be
the optimum processing conditions to obtain spherical hollow lipid particles. Ten percent
(d10%) and fifty percent of the particles (d50%) obtained with 50 μm and 200 bar were
smaller than 35.7 nm and 278 nm, respectively. Previously, Mandžuka and Knez (2008)
reported particle sizes of 10 to 40 µm for the tristearin particles obtained with a similar
process, but they did not report a hollow structure for their particles. Presence of
nanoparticles in the particles formed at 50 μm and 200 bar was further confirmed by
separation of the nanoparticles by filtration, and the morphology of the particles
investigated by TEM which showed the presence of spherical nanoparticles (Fig. 3.7).

Figure 3.7. a) Size distribution of the particles formed at 50 µm nozzle diameter and 200
bar; b) Size distribution of the nanoparticles obtained from the particles formed at 50 µm
nozzle diameter and 200 bar through filtration using 0.45 μm syringe filter; and c)
Transmission electron microscopy (TEM) image of the nanoparticles obtained from
particles formed at 50 µm nozzle diameter and 200 bar through filtration using 0.45 μm
syringe filter.
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3.4.3. Effect of processing conditions on the polymorphism
Polymorphism of the bioactive-loaded solid lipid particles affects the melting
properties of the particles and release profile of the bioactives. Figure 3.8 reveals the
effects of nozzle diameter and pressure on the polymorphism of the hollow solid particles
obtained from FHSO. Fats can crystallize in three main polymorphic forms, namey, α, β’,
and β. Polymorphic form α is the unstable form, β is the most stable form, and the β’ is
the metastable form (Rousseau, Marangoni, & Jeffrey, 1998). The polymorphic forms are
characterized by short spacings (d) obtained from XRD patterns, which is the distance
due to lateral packing of the fatty acid chains on the triacylglycerol molecules (Ten
Grotenhuis, Van Aken, Van Malssen, & Schenk, 1999). The short spacing at d=0.37 nm
and d= 0.46 nm indicated that the predominant polymorphic forms of bulk FHSO were β
and β’, respectively. The main polymorphic form in all particles changed to α (d= 0.41
nm) with decreasing nozzle diameter and pressure. The shift from β to α form was
observed as a main XRD peak at d=0.41 for the particles obtained with 75 and 50 µm
nozzle diameters. Main polymorphic form of the particles obtained with 100 µm was β at
300 bar; however, α form became more pronounced with decreasing nozzle diameter to
50 µm. The particles obtained with 100 µm and 120 bar had a major peak for α and a
small β peak. The nozzle diameter of 75 µm yielded a main polymorphic form of α and a
less pronounced form of β at 200 and 300 bar; however, 120 bar yielded particles with
only α polymorphic form. Different from nozzles with 75 and 100 µm diameter, nozzle
with 50 µm diameter formed particles with a single polymorphic form of α at all studied
pressures.
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Figure 3.8. X-ray powder diffraction (XRD) patterns showing the effect of the particle
formation conditions on the polymorphism of the hollow solid lipid particles.

The more stable the crystal structure (β), the more organized the molecules
packing within the lattice and could make expelling of the entrapped compounds out of
the particle possible (Lawler & Dimick, 2008; Helgason et al., 2009). This kind of
expelling is not expected for the particles obtained in this study because the particles are
hollow, which can be an advantageous over SLN which are full solid lipid particles. The
dense packing of the β form may also prevent the release of the loaded bioactives
(Heurtault, Saulnier, Pech, Proust, & Benoit, 2003).

3.4.4. Melting properties
Melting properties of the lipid particles are of great importance for achieving ideal
and controlled release of lipid micro and nanoparticles loaded with bioactives or/and
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drugs. Figure 3.9 presents the DSC melting curves of FHSO and the lipid particles
obtained from FHSO using different nozzle diameters and pressures. Understanding the
melting behavior of the particles was complicated due to the presence of different
polymorphic forms and particle size in the same sample.

Figure 3.9. Differential scanning calorimetry (DSC) curves showing the effect of the
particle formation conditions on the melting profile of the hollow solid lipid particles.

Lipid particles presented a different melting profile compared to the FHSO.
FHSO exhibited a single endothermic peak, whereas lipid particles exhibited a stepwise
melting and a broader melting range, and also melting temperature of the particles
decreased compared to the FHSO. Even though the fatty acid composition of the lipid
particles did not change, they had two major melting peaks as opposed to single melting
peak in FHSO. The differences in the melting profiles of the particles obtained with
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different processing conditions were attributed to the particle size differences and the
presence of different polymorphic forms. The main reason for the lower melting point of
the particles was attributed to particle size. From thermodynamics point of view, melting
temperature of colloidal substances decreases with decreasing particle size (Defay,
Prigogine, Bellemans, & Everett, 1966). This behavior has been observed for both
inorganic (Lai, Guo, Petrova, Ramanath, & Allen, 1996) and organic nanoparticles
(Westesen et al., 1997). Bunjes et al. (2000) reported that the melting behavior of
triacylglycerol nanoparticles strongly depended on particle size irrespective of the matrix
material. Lipid particles obtained in this study had a broader melting range and lower
onset temperatures compared to the single sharp melting peak of FHSO. Melting point
depression of the triacylglycerol nanoparticles compared to their bulk phase has also been
explained using the Gibbs-Thompson equation previously (Siekmann & Westesen, 1994).
The broading in the melting range and shift in the onset temperature to lower
temperatures were due to the small size of the particles. In a good agreement with our
findings, Bunjes et al. (2000) reported that the coarser dispersions of monoacid
triacylglycerols melt in a single transition at a slightly lower temperature that of the bulk
one; however, the melting range broadens and shifts to lower temperatures with
decreasing particle size. They also reported that the melting of both monoacid and
complex very fine triacylglycerols is stepwise rather than a continuous melting. Particles
obtained with 75 and 100 µm nozzle diameters at all pressures had similar melting
profiles except the one obtained with 100 µm and 300 bar; it had a melting curve similar
to that of FHSO due to the main polymorphic form of β and presence of very weak α
form. Particles obtained with 75 and 100 µm nozzle had three melting peaks (53 °C,

78

63 °C, and 67 °C); whereas particles obtained with 50 µm nozzle exhibited two melting
peaks (53 °C and 63 °C). The presence of the peak at 53 °C became more pronounced
with increasing intensity of the α peak on the XRD graph, and the peak at 63 °C was
attributed to the β form. The α form was less pronounced in the particles obtained with
100 µm and 300 bar; therefore, their melting peak at 63 °C was smaller. Similarly,
particles obtained with 75 µm nozzle and 120 bar had a more intense α peak (Fig. 3.8);
therefore, it had a bigger melting peak at 63 °C (Fig. 3.9). All particles had a lower
melting point peak at 53 °C, which was not available in the FHSO regardless the nozzle
diameter, pressure, and the XRD peaks. The XRD patterns showed that the particles
obtained with 50 µm had a single α peak; however, they exhibited two DSC melting
peaks. The melting peak of the particles from 50 µm nozzle diameter at 63 °C was due to
the α form, whereas the lower melting point melting peaks at 53 °C was attributed to the
small size of the particles from all nozzle diameters.

3.5. Conclusions
Hollow solid lipid micro- and nanoparticles were successfully formed from FHSO
by the atomization of the SC-CO2-expanded molten FHSO. Hollow solid lipid
microparticles were obtained using 75 and 100 µm nozzle diameters between the pressure
range of 120 and 300 bar; whereas, a mixture of micro- and nanoparticles were obtained
using 50 µm nozzle diameter. Processing conditions of 50 µm and 200 bar was found to
be the optimum conditions to yield intact smaller hollow solid lipid particles. The size of
the 50% of the particles obtained with 50 µm nozzle diameter was smaller than 278 nm.
Increasing nozzle diameter and pressure affected the particle morphology and size
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negatively. Shell thickness of the particles decreased with increasing pressure at the same
nozzle diameter. Decreasing the nozzle diameter changed the polymorphism of the
particles from β to α. Particles obtained with 50 µm nozzle diameter had only α form.
Melting behavior of the FHSO particles strongly depended on the particle size;
decreasing particle size broadened the DSC melting range and shifted the melting range
to lower temperatures. Hollow solid lipid micro- and nanoparticles are promising carriers
for bioactives that can be used as food ingredients to develop health and wellness
promoting foods and beverages. They are more advantageous over SLN because the
hollow particles have higher loading capacity, and the dry free-flowing powder form
makes it easy to use, transport, and store.
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CHAPTER 4. DEVELOPMENT OF ANTIBACTERIAL FREE-FLOWING
PEPPERMINT ESSENTIAL OIL-LOADED HOLLOW SOLID LIPID MICROAND NANOPARTICLES USING SUPERCRTIAL CARBON DIOXIDE*

4.1. Abstract
The main objective of this study was to overcome the issues related to the
volatility and strong smell of essential oils that limit their utilization as “natural”
antimicrobials in the food industry. Peppermint essential oil-loaded hollow solid lipid
micro- and nanoparticles were formed using a novel “green” method based on
atomization of CO2-expanded lipid mixture. The highest essential oil loading efficiency
(47.5%) was achieved at 50% initial essential oil concentration at 200 bar expansion
pressure and 50 μm nozzle diameter. After 4 weeks of storage, 61.2%, 42.5%, 0.2%, and
2.0% of the loaded essential oil was released from the particles formed at 5%, 10%, 20%,
and 50% (v/v) initial essential oil concentrations, respectively. Moreover, essential oilloaded particles obtained at 50% initial essential oil concentration caused 3 log decrease
in the growth of Pseudomonas fluorescens, which was significant higher than only 2 log
decrease at free essential oil (p<0.05). This innovative simple and clean process can form
spherical hollow micro- and nanoparticles loaded with essential oil that can be used as
food grade antibacterials.
Keywords: Essential oil; Microparticle; Nanoparticle; Lipid; Supercritical carbon
dioxide; Encapsulation.

* A version of this chapter has been published. Yang, J., & Ciftci, O. N. (2016). Development of
free-flowing peppermint essential oil-loaded hollow solid lipid micro- and nanoparticles via
atomization with carbon dioxide. Food Research International, 87, 83-91.
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4.2. Introduction
In recent years, there is a growing demand for foods prepared using “natural”
antimicrobials and antioxidants. However, many of those “natural” compounds that can
be used as antimicrobials and antioxidants are lipophilic, meaning water-insoluble, and
degrade easily during storage when exposed to oxygen and light. Therefore, addition of
the lipophilic compounds into foods and beverages has been a major challenge in the
food industry and remained as a barrier in front of the utilization of many “natural”
compounds to be used as antimicrobials and antioxidants. The need for efficient, simple,
and clean methods to incorporate lipophilic bioactive compounds in food systems has
urged the development of new delivery systems. Lipids could play a key role in the
delivery systems due to their physiological composition well tolerated by the human body
(Davis, 2004; Heurtault et al., 2003; Severino et al., 2012). Among lipid based carrier
systems, solid lipid nanoparticles (SLN) have advantages over other colloidal carriers
such as liposomes and nanoemulsions regarding the better stability and protection of the
incorporated bioactive compounds (Müller et al., 2002; Scalia et al., 2015). Nevertheless,
as mentioned in Chapter 3, current SLN production methods are either multi-steps, or
some of them involve organic solvents, or have severe processing conditions damaging
sensitive bioactives (Sampaio de Sousa et al., 2007). Moreover, SLN have low loading
capacity, and may expel the loaded bioactive during crystallization and storage due to
solid lipid core (Mukherjee et al., 2009).
As presented in Chapter 3, formation of free-flowing hollow solid lipid microand nanoparticles using SC-CO2 can overcome the limitations of the current SLN. In that
process, SC-CO2 was used as an expander and atomizer to form hollow solid lipid micro-
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and nanoparticles. The process is also able to decrease the melting point of the solid
lipids, which allows us to decrease the energy consumption and also protect the heat
sensitive compounds during processing. Single step process without the use of any
organic solvent, need for moderate pressurization, and need for low amount of CO2 make
it feasible to scale up.
In this study, the process developed in Chapter 3 was used to load the hollow
solid lipid micro- and nanoparticles with a lipophilic bioactive oil, namely essential oil, to
develop food grade antibacterials, and also to test the performance of the hollow solid
lipid particles as liquid oil carrier. Peppermint essential oil is a “natural” antimicrobial,
but its high volatility, vulnerability to heat, light and oxygen, and strong smell make it
difficult to use as antimicrobials in foods (Varona et al., 2010). In this work, essential oil
was loaded into the hollow solid lipid micro- and nanoparticles using the developed
hollow solid lipid micro- and nanoparticle formation process to overcome the abovementioned limitations associated with the use of essential oils in foods.
Previously, Varona et al. (2010) formed lavandin essential oil with biopolymers
by a similar process called Particles from Gas Saturated Solutions (PGSS) and PGSSdrying processes, respectively, and found out that encapsulation efficiency of lavandin oil
was between 14-66% in polyethylene glycol (PEG) microcapsules. Varona et al. (2013)
further explored the antimicrobial activity of the same lavandin essential oil formulations
against pathogenic foodborne bacteria. They showed that lavandin oil’s antibacterial
activity could be enhanced by encapsulation, and encapsulation might present an
opportunity to facilitate the action of essential oil as antimicrobial agent penetrating
inside the outer membrane.
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The main objective of this study was to load the hollow solid lipid micro- and
nanoparticles with essential oil to develop food grade free-flowing powder antibacterials
using the process developed in Chapter 3. The specific objectives were to: i) load
peppermint essential oil into the hollow solid lipid micro- and nanoparticles made of
FHSO, ii) determine the essential oil loading efficiency, particle morphology, particle
size and size distribution, and melting properties, iii) determine the release profile of the
loaded essential oil, iv) investigate the storage stability of the essential oil-loaded
particles in terms of particle morphology and size, and v) evaluate the antibacterial
activity of the essential oil-loaded hollow particles on Pseudomonas fluorescens.

4.3. Materials and methods
4.3.1. Materials
FHSO was kindly provided by ConAgra Foods Inc. (Omaha, NE, USA). CO2
(99.99% purity) was purchased from Matheson (Lincoln, NE, USA). Peppermint
essential oil (100% purity) was purchased from Nature’s (Streetsboro, OH, USA).
Pseudomonas fluorescens was obtained from American Type Culture Collection
(ATCC®), Manassas, VA. Tryptone Soya Broth (TSB) and Tryptone Soy agar (TSA)
were purchased from Becton, Dickinson and Company (Franklin Lakes, NJ, USA).

4.3.2. Production of the essential oil-loaded hollow solid lipid micro- and
nanoparticles using supercritical carbon dioxide
Essential oil-loaded hollow solid lipid micro- and nanoparticles were produced
using particle formation system described in Section 3.3.3. Temperature of the expansion
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vessel was maintained at 57 °C which is the melting point of FHSO at 120 bar CO2
pressure, and at this temperature the mixture of the FHSO and the essential oil is in the
liquid state. Temperature of the depressurization valve and nozzle was set to 20 °C above
the melting point of the FHSO under atmospheric conditions. Molten FHSO was placed
into the expansion vessel and then predetermined volumes of essential oil was injected
into the expansion vessel through the sampling port to obtain initial essential oil
concentrations of 5, 7, 10, 20, and 50% (v/v) in the FHSO. For each run, the total volume
of the FHSO and essential oil mixture in the vessel was kept constant at 20 mL; therefore,
the volumes of the essential oil injected into the vessel were 1, 1.4, 2, 4, and 10 mL for
initial essential oil concentrations of 5, 7, 10, 20 and 50% (v/v), respectively. The
sampling port was closed immediately after injecting the essential oil to prevent
evaporation of the essential oil. Then, the expansion vessel was pressurized with CO2 at
200 bar and the mixture in the vessel was mixed at 1000 rpm using the magnetic drive.
Upon mixing, the lipid mixture expanded due to dissolution of the SC-CO2 in the lipid
mixture. Then, the magnetic drive was turned off and the expanded lipid mixture was
stabilized for 10 min. The pressure of the syringe pump was set to 10 bar above the
pressure of the expansion vessel, and the CO2 inlet valve was opened, then
depressurization valve was opened and the mixture was atomized through a 50 µm
diameter nozzle. Upon depressurization, particles were formed and collected in the
sample collection vessel. Particle formation conditions (200 bar expansion pressure and
50 µm nozzle diameter) were based on the optimized conditions that yielded smallest
(d50% = 278 nm) hollow solid lipid micro- and nanoparticles in Chapter 3.
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4.3.3. Determination of the essential oil loading capacity and efficiency
Essential oil-loaded lipid particles (1 g) were spread on a light aluminum dish as a
thin layer and heated at 150 °C for 30 min to evaporate the essential oil. Essential oil
loading capacity (LC) and loading efficiency (LE) were calculated according to Eq. (4.1)
and Eq. (4.2), respectively:

𝐿𝐶 (%) =

(𝑚𝑖 −𝑚𝑓 )
𝑚𝑓

×100

(4.1)

where mi is the initial mass of the sample, and mf is the mass of the sample after heating.

𝐿𝐸 (%) =

𝐿𝐶𝑒
𝐿𝐶𝑡

×100

(4.2)

where LE is the loading efficiency, LCe is the experimental loading capacity obtained
from Eq. (4.1), and LCt is the theoretical loading capacity, which is the initial weight
concentration of the essential oil in the lipid mixture used for particle formation. Weight
concentrations were calculated by weighing the amounts of the FHSO and the essential
oil used for each particle formation.

4.3.4. Determination of the particle size and size distribution
Particle size and size distribution of the essential oil-loaded lipid particles were
measured using a laser diffraction particle size analyzer (Mastersizer 3000, Malvern
Instruments Ltd., Worcestershire, UK) as described in Section 3.3.4.
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4.3.5. Scanning Electron Microscopy analysis
Morphology of the particles was analyzed using a Field Emission-Scanning
Electron Microscope (FE-SEM) (S4700, Hitachi High-Technologies Corporation, Japan)
as described in Section 3.3.5.

4.3.6. Transmission Electron Microscopy analysis
Hollow structure of the nanoparticles was examined using a Transmission
Electron Microscope (TEM) (H7500, Hitachi High-Technologies Corporation, Japan) as
described in Section 3.3.5.

4.3.7. Confocal fluorescence microscopy analysis
Essential oil-loaded lipid particles obtained at 10, 20 and 50% (v/v) initial
essential oil concentration were analyzed using a confocal fluorescence microscope (A1,
Nikon Instruments Inc., Japan) to investigate the loading of the essential oil in the hollow
solid lipid micro- and nanoparticles since peppermint essential oil exhibits visible
florescence. Essential oil-loaded lipid particles were dispersed in distilled water without
the addition of Tween 80. The dispersions were then vortexed and sonicated using an
ultrasonic water bath (3510 R-MTH, Branson Ultrasonics Corporation, Danbury, CT,
USA) for 30 min before each analysis. The confocal images were recorded by a
fluorescence microscope (90i, Nikon Instruments Inc., Japan) using z series scanning at
each distance of 0.5 µm. Analyses were conducted at the excitation wavelengths of 405
nm and 488 nm and emission wavelengths of 450 nm and 525 nm.
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4.3.8. Determination of the melting profile
Melting profile of the essential oil-loaded lipid particles was determined using a
differential scanning calorimeter (DSC) (Pyris 1, Perkin Elmer, Waltham, Massachusetts,
USA) as described in Section 3.3.7.

4.3.9. Release profile of the essential oil loaded in the hollow solid lipid micro- and
nanoparticles
Four grams of essential oil-loaded particles with 5, 10, 20 and 50% (v/v) initial
essential oil concentration were stored in closed containers at room temperature (22 °C)
for 6 weeks and the amount of released essential oil was determined from the weight
difference weekly over 6 weeks.

4.3.10. Storage stability of the essential oil-loaded hollow solid lipid micro- and
nanoparticles
The storage stability of the essential oil-loaded hollow solid lipid micro- and
nanoparticles (5, 10, 20 and 50%, v/v, initial essential oil concentration) was investigated
in terms of changes in particle size and size distribution and particle morphology over 6
weeks of storage at room temperature (22 °C) in closed containers. Samples were
analyzed every week with particle size analyzer and FE-SEM as described in Sections
3.3.4 and 3.3.5, respectively.
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4.3.11. Antibacterial assays
4.3.11.1. Bacterial strain and culture media
The strain studied in evaluating the antibacterial activity of the essential oilloaded hollow solid lipid micro- and nanoparticles was a Gram-negative bacterium,
Pseudomonas fluorescens. The culture media used for the strain was Tryptone Soya
Broth (TSB).

4.3.11.2. Plate count assay
The plate count assay was performed to determine the antibacterial activity of free
peppermint essential oil and peppermint essential oil loaded into the hollow solid lipid
micro- and nanoparticles. Briefly, a predetermined quantity of free essential oil (111 µL),
particles obtained at 50% (v/v) initial essential oil concentration (0.5 g) to achieve
essential oil concentration of 10 mg/mL or empty unloaded particles alone (0.2 g) was
dissolved in 10 mL bacteria suspension (106 CFU/mL) in TSB medium and incubated at
25 °C during 24 h with a gentle agitation (100 rpm). Control was performed with only
bacteria suspension in TSB medium. After incubation, appropriate serial dilutions of each
culture in physiologic solution were conducted and spread on the surface of the solidified
agar plates (TSA medium). Microorganism colonies were counted after 24 h of
incubation at 25 °C to calculate the percentage of log inhibition of each system according
to the following equation (Pettit et al., 2005), where C is the bacterial colonies counted
for the negative control (bacteria free growth without addition of essential oil) and
samples (bacteria growth in the presence of free or loaded essential oil).
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% 𝑙𝑜𝑔 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =

𝐶 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)− 𝐶 (𝑠𝑎𝑚𝑝𝑙𝑒)
𝐶 (𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)

×100

(4.3)

4.3.12. Statistical analysis
Data are presented as mean ± standard deviation based on triplicate experiments
and analyses. Statistical analysis of the data was performed by using SAS (version 9.3)
software package (SAS Institute Inc., NC, USA) at 95% confidence interval.

4.4. Results and discussion
4.4.1. Essential oil loading efficiency
Figure 4.1 presents the essential oil loading efficiency obtained at different initial
essential oil concentrations. There was no significant difference between the loading
efficiencies at 5, 7, 10, and 20% initial essential oil concentrations (p>0.05); however, it
was significantly higher at 50% initial essential oil concentration (p<0.05). The essential
oil loading efficiency increased from 39.0 to 47.5% when the initial essential oil
concentration increased from 20 to 50%. During particle formation, the
amount of essential oil available for loading is lower than the initial amount of essential
oil introduced into the expansion vessel. Two phases were formed in the expansion
vessel; the bottom phase was CO2-expanded liquid phase that consisted of mixture of
FHSO, essential oil, and CO2, and the upper gas phase consisted of SC-CO2. Upon
mixing, the essential oil was equilibrated between the two phases by diffusing into the
upper SC-CO2 phase. Because the amount of total lipid mixture was kept constant in each
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run, the amount of the SC-CO2 in the upper phase was constant. At higher essential oil
concentration, there was more essential oil in the liquid phase after the upper phase was
saturated by the essential oil; therefore, there was more essential oil in the CO2-expanded
lipid phase. As a result, more essential oil was loaded into the lipid particles during
depressurization of the CO2-expanded lipid mixture. A similar phenomenon was reported
for enzymatic synthesis of fatty acid methyl esters from methanol and corn oil (Ciftci &
Temelli, 2011). It was reported that the substrate molar ratio of methanol to oil changed
in the reaction mixture due to diffusion of methanol into the upper SC-CO2 phase which
resulted in less methanol in the CO2-expanded liquid phase where the reaction took place
(Ciftci & Temelli, 2011). These results suggested that the amount of essential oil loaded
into the particles will be different than the initial concentration depending on the particle
formation conditions, namely, pressure, temperature, ratio of lipid mixture to the SC-CO2
phase, and expansion time.

Figure 4.1. Loading efficiency at varying initial peppermint essential oil concentrations.
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4.4.2. Particle morphology
Figure 4.2 shows the morphology of the essential oil-loaded lipid particles
obtained at different initial essential oil concentrations. In Chapter 3, it has been found
that increasing nozzle diameter affected the particle morphology negatively; particles lost
their spherical shape and smooth surface at bigger nozzle diameters (75 and 100 μm) at
all studied pressures (120, 200 and 300 bar). Essential oil-loaded spherical particles were
successfully generated, which could provide homogenous mixing during formulation, and
achieve more controlled release of the loaded essential oil (Mu & Feng, 2003). As
explained in Chapter 3, the CO2-expanded lipid was atomized through the nozzle, and
formed small liquid lipid droplets containing pressurized CO2. Upon atomization, the
compressed CO2 in the lipid droplets expanded and formed a liquid lipid bubble. At the
same time, the temperature decreased below the solidification temperature of the solid
lipid due to Joule-Thompson effect and the lipid bubble solidified and formed a spherical
hollow solid lipid particle. During solidification, the FHSO encapsulated the liquid
essential oil in the inner cavity.
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Figure 4.2. (a)-(e) Scanning electron microscopy (SEM) images of the essential oil
loaded hollow solid lipid microparticles obtained at varying initial essential oil
concentrations (v/v): (a) 5%, (b) 7%, (c) 10%, (d) 20%, and (e) 50%; (f) Transmission
electron microscopy (TEM) image of the essential oil-loaded lipid nanoparticles obtained
at 50% initial essential oil concentration after filtration using 0.45 μm filter.

SEM images shown in Figure 4.2 indicated that the initial essential oil
concentration affected the morphology of the essential oil-loaded lipid particles. At lower
initial essential oil concentrations (5-7%), the essential oil-loaded lipid particles had a
smooth surface; however, increasing initial essential oil concentration to 20-50% resulted
in formation of particles with wrinkled-like surface. During particle formation, higher
amount of essential oil evaporated from the lipid bubble due to high volatility and
therefore particles had an irregular surface during sudden solidification. The
agglomeration of the lipid particles became more pronounced with increasing initial
essential oil concentration, suggesting that there was essential oil on the surface of the
particles which made the final product sticky. A similar agglomeration was observed by
Varona et al. (2010) for the production of lavandin essential oil-loaded biopolymer
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polyethylene glycol (PEG) particularly with increasing the oil to PEG ratio from 0.25 to
0.37.
Figure 4.3 presents the cross-sectional images of the essential oil-loaded hollow
solid lipid particles obtained by z series scanning by confocal fluorescence microscopy.
Figure 4.3 reveals that the peppermint essential oil, shown in dark blue color, was loaded
mainly in the cavity and some in the shell of the particles. When a laser z series scanning
was applied, the fluorescence gradually appeared and became more predominant in the
cavity, as well as in the particle shell. Presence of the essential oil in the solid lipid shell
was due to entrapment of the essential oil in the shell during sudden solidification of the
lipid mixture and also release of the essential oil through the solid lipid shell after particle
formation for some particles.

Figure 4.3. Confocal fluorescence microscopy z-series scanning images of the essential
oil-loaded hollow solid lipid micro- and nanoparticles obtained at varying initial essential
oil concentrations (v/v): (a) 10%, (b) 20%, and (c) 50%.

4.4.3. Particle size and size distribution
Particles obtained at all initial essential oil concentrations exhibited a bimodal
size distribution (Fig. 4.4). Powder solid lipid particles consisted of both nanoparticles
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and microparticles. The smallest particles were obtained at 5% initial essential oil
concentration (d10%= 0.0809 µm, d50%= 6.06 µm, and d90%= 13.1 µm). Ten percent (d10%),
fifty percent (d50%) and ninety percent (d90%) of the particles formed at 50% initial
essential oil concentration were smaller than 0.0811 µm, 7.24 µm, and 18.3 µm,
respectively. During particle formation, essential oil exerted pressure from inside of the
liquid lipid bubble in addition to CO2 and expanded the bubble. At lower essential oil
concentration, there was lower force acting from inside of the lipid bubble which resulted
in smaller particles.

Figure 4.4. Particle size and size distribution of the essential oil-loaded hollow solid lipid
micro- and nanoparticles obtained at varying initial essential oil concentrations: (a) 5%,
(b) 7%, (c) 10%, (d) 20%, and (e) 50%.

The particle size and size distribution were similar among the particles obtained at
all initial essential oil concentrations; however, the size of the essential oil-loaded lipid
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particles increased compared to empty particles (d10%= 0.0357 µm, d50%= 0.278 µm,
d90%= 11.2 µm). It should be noted that the particle size results may be affected by the
agglomeration of the particles; therefore, it must be compared with the SEM analyses.
When SEM images of the empty and loaded particles were compared, it was observed
that the particles agglomerated due to the presence of smaller amounts of essential oil on
the particle surface which made the particles sticky (Fig. 4.5).

Figure 4.5. Scanning electron microscopy (SEM) images of the empty and essential oilloaded hollow solid lipid micro- and nanoparticles obtained at varying initial essential oil
concentrations (v/v): (a) 0, (b) 5%, (c) 7%, (d) 10%, (e) 20%, and (f) 50%.

Previously, Leimann, Gonçalves, Machado, and Bolzan (2009) reported that when
the essential oil volume fraction increased from 3.4 to 7.4%, the size distribution tended
to be bimodal, particle diameter increased, and particle size distribution became broader
during microencapsulation of lemongrass essential oil by simple coacervation. Similarly,
Varona et al. (2010) reported that the mean particle size (d50%) of the lavandin oil-loaded
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polymer obtained with PGSS increased with increasing encapsulated lavandin oil content
(d10% = 10 µm, d90%= 500 µm). In another study, encapsulation of essential oil using
PGSS generated larger garlic essential oil-loaded PEG 6000 particles with a particle size
ranging from 71 to 206 µm (Gitin et al., 2011). However, those studies did not report a
hollow structure, and the particle sizes were only in the micron range.

4.4.4. Melting properties
Melting behavior of the essential oil-loaded solid lipid particles plays an
important role in the storage and release properties of the loaded essential oil. Figure 4.6
presents the DSC melting curves of the hollow solid lipid particles loaded with
peppermint essential oil. The original FHSO melted between 69.4 °C and 73.1 °C with a
single endothermic melting peak at 71.7 °C. Even though the fatty acid composition of
the hollow solid lipid particles obtained from FHSO and the original FHSO is the same,
the major melting peak of the lipid particles obtained at 5, 7, 10, 20 and 50% initial
essential oil concentrations gradually shifted to relatively lower onset melting
temperatures compared to the original FHSO, and this trend became more pronounced
when initial essential oil concentration was increased to 50%. The major melting peak of
the particles with 5% initial essential oil concentration was 70 °C, whereas it was 65 °C
for the ones with 50% initial essential oil concentration. In Chapter 3, it was shown that
the presence of lower melting peaks at 53 °C for the empty hollow solid lipid particles
was due to presence of nanoparticles; however, no pronounced melting peak was
observed at 53 °C at the initial essential oil concentrations above 7% in this study. This
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was attributed to the agglomeration of the particles at increased initial essential oil
concentrations.

Figure 4.6. Differential scanning calorimetry (DSC) melting curves of the essential oilloaded hollow solid lipid micro- and nanoparticles obtained at varying initial essential oil
concentrations.

4.4.5. Release profile of the essential oil
Release profile of the essential oil from the lipid particles during storage is
presented in Figure 4.7. The results indicated that the release of the loaded essential oil
varied with its initial concentration used for particle formation. Although the lipid
particles obtained at 5, 10 and 20% initial essential oil concentration had comparable
essential oil loading efficiencies, they exhibited different release profiles during storage.

101

Figure 4.7. Release profile of the essential oil from the hollow solid lipid micro- and
nanoparticles during 6 weeks of storage at room temperature (22 °C).

Particles obtained at 5 and 10% initial essential oil concentration exhibited higher
release of the loaded essential oil than that of the lipid particles obtained at 20 and 50%
initial essential oil concentration. The amount of essential oil released at 5, 10, 20 and
50% initial essential oil concentration after 1 week of storage was 36.5, 20.9, 0.7, and
1.6%, respectively. With increasing storage time, the amount of released essential oil
increased for the lipid particles obtained at 5 and 10% initial essential oil concentration,
whereas stayed almost constant for the particles obtained at 20 and 50% initial essential
oil concentration. After 4 weeks of storage, the released essential oil in lipid particles at
5, 10, 20 and 50% initial essential oil concentration reached 61.2, 42.5, 0.2, and 2.0%,
respectively, and then stayed constant until week 6. Lower release from the particles
obtained at higher initial essential oil concentrations was attributed to the stronger shell
of the lipid particles obtained at high initial essential oil concentrations. During particle
formation, there was more essential oil in the lipid mixture at higher initial essential oil
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concentrations which formed a viscous lipid mixture and in turn formed a stronger lipid
shell consisted of FHSO and essential oil compared to particles obtained at lower initial
essential oil concentrations. Presence of more essential oil in the lipid shell, observed by
confocal fluorescence microscopy, but no release of the essential oil from those particles
confirmed this finding. Unchanged morphology of the particles obtained at 20 and 50%
initial essential oil concentration during storage also showed that there was no release of
the essential oil from those particles at the studied storage conditions (Fig. 4.8). The
study of Varona et al. (2010) also suggested the amount of released essential oil mainly
related to the initial amount of essential oil in the initial emulsion and the amount of oil in
the final product where lavandin essential oil was encapsulated in starch in their study.
However, it should be noted that the release profile does not only depend on the initial
concentration of the loaded compound but also the encapsulation matrix as observed in
this study. In another study, the release of the fragrances from a polymer matrix was
dominated by the interaction between the fragrance and polymer matrix rather than vapor
pressure and boiling point of the fragrance (Sansukcharearnpon, Wanichwecharungruang,
Leepipatpaiboon, Kerdcharoen, & Arayachukeat, 2010).
We also tested the release of the essential oil from the particles obtained at 50%
initial essential oil concentration stored at 25 °C after 24 h, which was the condition used
for the further determination of antibacterial effect against Pseudomonas fluorescens.
There was 2.77% essential oil released and was higher than that of the particles stored at
room temperature (22 °C) releasing only 2.0% after 4 weeks (Fig. 4.7), which was due to
the difference in storage temperature; relatively higher temperature prompted the release.
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Figure 4.8. Scanning electron microscopy (SEM) images of the essential oil-loaded
hollow solid lipid micro- and nanoparticles during 4 weeks of storage at room
temperature (22 °C).

4.4.6. Storage stability of the essential oil-loaded hollow solid lipid micro- and
nanoparticles
Storage stability is an important parameter that must be studied for such products
intended to be used in food preparations that will be stored. Change in the morphology of
the particles loaded with essential oil is one of the most important studies that needs to be
conducted. Integrity of the particles is needed to keep the essential oil in the lipid
particles. Change in the morphology of the particles will also give information about the
release properties of the loaded essential oil. Figure 4.8 presents the change in the
morphology of the essential oil-loaded lipid particles over 4 weeks of storage at room
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conditions. Morphology of the particles changed at 5% and 10% initial essential oil
concentration due to release of the loaded essential oil through the solid lipid shell.
Particles with 5 and 10% initial essential oil concentration lost their smooth surface but
the particles preserved their spherical shape. The flaky surface structure was due to the
evaporation of the essential oil through the solid lipid shell. Even though no major
changes in the morphology of the particles obtained at 20 and 50% initial essential oil
concentration were observed during storage, the change in the particles with 20% initial
essential oil concentration was more pronounced compared to that of 50%. This was due
to very low release of the loaded essential oil, which was also supported by the very low
release of the essential oil from these particles shown in Figure 4.7. Even though
morphology of the individual particle is important to understand the storage stability of
the particles in terms of particle morphology, it is also important to understand the
behavior of bulk particles. Figure 4.9 presents that the particles that exhibited change in
the surface morphology during storage tended to stick to each other and form nonspherical bigger agglomerates. During storage, essential oil released from the particles
and formed a sticky surface; therefore, particles agglomerated. However, even though an
agglomeration was observed for the particles obtained at 50% initial essential oil
concentration, those particles stayed intact and spherical due to very low release of the
essential oil.
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Figure 4.9. Scanning electron microscopy (SEM) images of the essential oil-loaded
hollow solid lipid micro- and nanoparticles in the third week of the storage at room
temperature (22 °C): (a) 5%, (b) 10%, (c) 20%, and (d) 50%.

Change in the morphology of the essential oil-loaded lipid particles was also
studied at refrigeration condition, which is another storage temperature for food products
in addition to room temperature. It was found that the change in the morphology was
greatly affected by the storage temperature. Particles stored at refrigeration temperature
(4 °C) did not exhibit the morphological changes observed at room temperature (Fig.
4.10). The surface of the particles obtained at 5% initial essential oil concentration
became flaky at room temperature, whereas there was no change in the same particles at
refrigeration temperature because of very low release of the essential at low temperature
due to lower evaporation of the essential oil.
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Figure 4.10. Scanning electron microscopy (SEM) images of the morphology of the
essential oil-loaded hollow solid lipid micro- and nanoparticles stored at 4 °C: (a)
particles obtained at 5% initial essential oil concentration stored at 4 °C for 2 months, and
(b) particles obtained at 20% initial essential oil concentration stored at 4 °C for 2
months.

Storage stability was also investigated in terms of particle size. Figure 4.11
presents the change in the particle size of the essential oil-loaded particles during storage
at room temperature. Particle size increased after 1 week of storage for all particles due to
agglomeration caused by the released essential oil. The agglomeration was more
pronounced after first week due to more released essential oil. The mean particles size
increase during the 6 weeks of storage was from 5.9 to 37.5 µm, 6.0 to 37.1 µm, 7.8 to
32.3 µm, and 6.7 to 32.1 µm for essential oil-loaded lipid particles obtained at 5, 10, 20
and 50% initial essential oil concentration, respectively. This agglomeration was also
observed by SEM imaging as mentioned before (Fig. 4.9). It should be noted that the
particle size analysis and SEM analysis should be carried out together to understand if the
differences in the size are due to agglomeration or broken pieces of the particles. The
changes in particle morphology and size could help to explain release profile of the
loaded essential oil. The release of the loaded essential oil not only depends on the shell
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strength and the amount of essential oil trapped in the particle shell, but also on the
particle size; smaller particles have higher surface-to-volume ratio which could result in a
greater release of the essential oil (Pedro, Santo, Silva, Detoni, & Albuquerque, 2013).
The mean particles size of essential oil-loaded lipid particles was 10.3 µm, 16.4 µm, 22.6
µm and 25.9 µm at 5, 10, 20 and 50% initial essential oil concentration after the first
week of storage, respectively. Initial essential oil concentration of 5% produced the
smallest particles, whereas 20 and 50% produced the largest particles, and 10% was in
between, suggesting that the release of essential oil was easier from the particles with 5
and 10% initial essential oil concentrations, which agreed with the release profile results.
Similar agglomeration was observed by Hill, Gomes, and Taylor (2013) for their essential
oil-𝛽-cyclodextrin complexes. In another study, this agglomeration was attributed to the
binding of oil together with spheres via capillary forces (Wendt, Brandin, Kilzer,
Weidner, & Peterman, 2007).
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Figure 4.11. Mean particle size of the essential oil-loaded hollow solid lipid micro- and
nanoparticles stored for 6 weeks at room temperature (22 °C).

4.4.7. Antibacterial effect of the essential oil in lipid particles on Pseudomonas
fluorescens
The antibacterial activity of the essential oil in both lipid particles obtained at
50% initial essential oil concentration and free formulation tested against Gram-negative
strain Pseudomonas fluorescens is presented in Fig. 4.12. It is more difficult to treat
Gram-negative bacteria than Gram-positive bacteria due to the presence of an outer
membrane, porin channels, antibiotics resistance, and both exotoxins and endotoxins.
Therefore, Pseudomonas fluorescens, one of the major food spoilage Gram-negative
bacteria, was selected in this study. The concentration of the essential oil in both loaded
and free form was set at 10 mg/mL. This concentration was chosen to have sensitivity to
detect differences of antibacterial activity among the samples, along with the fact that
higher concentrations of essential oil lead to strong inhibition effect, and therefore, the

109

same result could be obtained with all formulations studied. Pseudomonas fluorescens
tested in this study demonstrated some degrees of sensitivity of free and loaded essential
oil. Both free essential oil and loaded essential oil in lipid particles exhibited interesting
antibacterial activity against Pseudomonas fluorescens after 24 h of incubation in TSB
medium at 25 °C. Moreover, loading of the essential oil in the hollow solid lipid microand nanoparticles significantly improved the efficiency of antibacterial activity of
essential oil. It showed 3 log decrease in the bacterial growth compared to the empty
particles and negative control, and achieved the maximal log inhibition of 75%.
However, the inhibition caused by the free essential oil was significantly lower than the
inhibition caused by the same concentration of loaded essential oil in lipid particles
(p<0.05). Only 2 log decrease in the bacterial growth and 50% log inhibition was
observed for the free essential oil treatment. The improvement in efficiency against
bacterial growth of the essential oil in lipid particles could be due to the increment of the
active compounds given by a decrease of the other ingredients, which may have a low
volatile point (Arana-Sánchez et al., 2010). This improvement could also be related to the
increased solubility of the oil in water, improving the stabilization and bioavailability of
the guest molecule in broth mixture (Polyakov, Leshina, Konovalova, Hand, & Kispert,
2004). Consequently, the physical, chemical and biological properties of the loaded
molecules were modified (Mourtzinos, Kalogeropoulos, Papadakis, Konstantinou, &
Karathanos, 2008), enabling the loaded essential oil to achieve a controlled release with
higher potency. Previously, Varona et al. (2013) evaluated the antimicrobial activity of
encapsulated lavandin essential oil particles using PGSS, PGSS-drying, and spray-drying
against three pathogenic bacteria. They reported that lavandin oil antibacterial activity
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could be enhanced by encapsulation since it provided the protection and controlled
release of the oil.

Figure 4.12. Antibacterial inhibitory effect of essential oil-loaded hollow solid lipid
particles of 50% initial concentration at 10 mg/mL content.

4.5. Conclusions
Peppermint essential oil-loaded hollow solid lipid micro- and nanoparticles were
successfully formed from FHSO by a novel process based on atomization of the CO2expanded lipid mixture. The study generated important information on the essential oilloaded hollow solid lipid micro- and nanoparticle formation, storage stability of the
loaded particles, and the release properties of the essential oil from particles. The highest
loading efficiency (47.5%) was obtained at 50% initial essential oil concentration.
Storage stability studies showed that the release properties of the loaded essential oil
depended on the initial essential oil concentration, which affected the physical strength of
the solid lipid shell. During the 6 weeks of storage time at room temperature (22 °C),
particles generated at 5 and 10% initial essential oil concentration released 61.0 and
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42.5% of the loaded essential oil. Process could form spherical intact particles loaded
with essential oil at all studied conditions. Another unique advantage of the process is our
control over the shell thickness of the particles by changing the process pressure; thicker
shells can be obtained at lower pressures.
This innovative process to encapsulate essential oil in solid lipids under mild,
simple, and clean processing conditions allowed us to slow down the release of the
essential oil and minimize the strong smell that will be important for their use as natural
antimicrobials in foods. Study showed that the hollow solid lipid micro- and
nanoparticles are promising novel “natural” carrier systems for various bioactives. Nano
size allows us to prepare transparent beverages that contain lipophilic bioactives, which is
a challenge in food industry. The novel hollow solid lipid micro- and nanoparticles are
alternatives to the SLN, and overcome the issues associated with the SLN. The solid lipid
shell provides protection for the loaded compound while the hollow structure increases
the loading capacities. The dry free-flowing products also make the handling and storage
more convenient, and the simple and clean process makes the scaling up more feasible.
There is a growing demand for foods prepared using “natural” ingredients and therefore
food industry is in a constant search for “natural” food grade antimicrobials to eliminate
the artificial preservatives from foods. Developed peppermint essential oil-loaded hollow
solid lipid particles have the potential to be used as “natural” food antimicrobials. Using a
“clean” process is another advantage for food industry.
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CHAPTER 5. SUMMARY, CONCLUSIONS AND RECOMMENDATIONS

5.1. Summary and conclusions
This thesis has reported that hollow solid lipid micro- and nanoparticles from
FHSO can be used as promising bioactive-carriers using a green method based on
atomization of CO2-expanded lipids. Obtained hollow solid lipid particles were both in
micro- and nanosize, with high loading capacity, minimized or no bioactive expelling,
and provided bioactive protection and controlled release.
In Chapter 3, it has been found that pressure and nozzle diameter affected the
particle morphology negatively. Shell thickness of the particles decreased with increasing
pressure. Optimal processing condition was selected at 50 µm nozzle diameter and 200
bar expansion pressure, based on the particle morphology and size and distribution with
the preference of intact spherical smaller particles. Fifty percent of the particles obtained
under optimal condition was smaller than 278 nm. The major polymorphic form of the
particles changed from β to α with decreasing pressure and nozzle diameter, with
particles generated from 50 µm nozzle diameter had only α form. Decreasing particle size
to nanosize broadened the melting range and shifted the melting to lower onset
temperatures.
In Chapter 4, essential oil was successfully loaded in the hollow solid lipid microand nanoparticles at optimal particle formation conditions obtained in Chapter 3. The
highest loading efficiency of 47.5% was achieved at 50% initial essential oil
concentration. Initial essential oil concentration affected the particle morphology
negatively. Loaded essential oil in the particles obtained at 5 and 10% initial essential oil
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concentration released more than that of the particles obtained at 20 and 50%
counterparts after four weeks of storage at room temperature, achieved 61.2, 42.5, 0.2,
and 2.0%, respectively. Moreover, the particles obtained at 50% initial essential oil
concentration showed significant antibacterial activity against Pseudomonas fluorescens
than free essential oil, with 3 log decrease in bacterial growth after 24 h of incubation.
The study suggested that the essential oil-loaded hollow solid lipid micro- and
nanoparticles obtained by this simple and clean process can be used as food grade
antibacterials.
The hollow structure can increase the loading capacity significantly compared to
SLN, and solve the bioactive expelling problem of the SLN. This study explored hollow
solid lipid micro- and nanoparticles for food applications, and introduced a novel
production method with several advantages: 1) simple, energy efficient, and easy to
scale-up process; 2) green technology (i.e., no organic solvent was used and no waste
generated); 3) no degradation of bioactives due to mild processing temperature and
absence of oxygen; 4) can generate a variety of bioactive-loaded hollow solid lipid
micro- and nanoparticles to deliver omega-3 fatty acids, carotenoids, phytosterols and
natural antioxidants; 6) particles can be added directly to clear liquids without affecting
clarity; and 7) particles are free flowing dry powder which makes handling,
transportation, and storage convenient.

5.2. Recommendations
Understanding the effect of triacylglycerol structure and distribution of fatty acids
on the glycerol backbone on the melting and volumetric expansion of the solid lipids is
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critical to obtain particles from a number of solid lipids and to better understanding the
particle formation mechanism. In this thesis, we selected fully hydrogenated soybean oil
as the model solid lipid to construct the hollow solid lipid micro- and nanoparticles as the
bioactive-carrier. In the future planning, different solid lipid matrix should be studied to
further optimize the physicochemical properties of the lipid particles, for example,
release properties, solubility, and stability. Modifying the lipid shell my using mixtures of
mono-, di-, and triacylglycerols to create imperfections in the lipid shell to control the
release of the bioactive will help create particles designed for controlled release.
Even though we proposed a mechanism for the hollow particle formation in this
process, it will be useful to use computational fluid dynamics to simulate the particle
formation and temperature changes during atomization. In this thesis, it has been found
that pressure and sudden cooling during atomization determine the particle size and shell
thickness; however, such a simulation will help us better understand the effect of process
parameters on particle size and morphology.
Another future research that should be conducted to further complete the study is
the investigation of performance of the bioactive-loaded particles in real food systems,
and the in vitro and in vivo bioavailability of the loaded bioactives in the hollow solid
lipid micro- and nanoparticle. We should be able to know if the loaded bioactives can
withstand processing, be released from the food matrix after digestion and be
bioaccessible in the GI tract, undergo metabolism and reach the blood serum for action to
exert health benefits. Using the particles in selected food formulations and investigating
the effect of the particles on the quality and sensory properties of the end products will
help us determine specific food applications.

